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ABSTRACT OF THE DISSERTATION
AFRICAN AMERICAN AND AFRO-CARIBBEAN AMERICAN MEN’S PROSTATE
HEALTH KNOWLEDGE AND BELIEFS
by
Cora Yoose
Florida International University, 2015
Miami, Florida
Professor Ellen Brown, Major Professor
Approximately one in every seven American men will be diagnosed with prostate cancer
during his lifetime. Men of African descent have higher incidence and mortality rates
than others. Prostate cancer screening is important because the five-year survival rate is
only 31% post-metastasis. The purpose of this study was to assess the likelihood of
action for and factors influencing choice regarding prostate screenings. It was also to
determine if a relationship existed between ethnicity (African American and AfroCaribbean American men) and knowledge of prostate health, self-efficacy, perceived
barriers to and belief regarding prostate screening. Data collection methods included a
focus group (n = 8) among African American and Afro-Caribbean American men
(M = 53.8, 10.3) and self-administered surveys (n = 113) among African American
(n = 49, 45.4%) and Afro-Caribbean American (n = 38, 35.2%) men (M = 59.5, 16.4)
from churches in South Florida using convenience sampling and the Health Belief Model
(HBM) as a framework. Knowledge was assessed using a combined version of the
Knowledge and Practice of Prostate Health Questionnaire and Prostate Cancer Screening
Education (PROCASE) Knowledge Index. Self-efficacy was measured as decisional
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conflict reported from the Low Literacy Decisional Conflict Scale. Barriers were
identified from a Perceived Barriers Survey. Beliefs were measured as spiritual wellbeing and evaluated using the Functional Assessment of Chronic Illness TherapySpiritual Well-Being, a modified version for non-illness (FACIT-Sp Non-Illness).
Almost half of African American (47.9%) and nearly a third (29%) of Afro-Caribbean
American participants were unaware of participation or did not participate in prostatespecific antigen (PSA) testing. Findings indicated prostate screening concerns,
inadequate knowledge, past negative experiences, and cost may contribute to low prostate
screening rates. Both ethnicities did not differ in knowledge of prostate health or selfefficacy for making an informed decision regarding prostate screening. Potential targets
for outreach efforts among these ethnic groups could include faith-based medical
partnerships to diminish health disparities. Future intervention studies would benefit
from a focus on diverse cultures and ethnicities in different settings and culturally
appropriate strategies for nurses and other health professionals to use when assisting
patients with informed decision making regarding prostate cancer screening.
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CHAPTER I
INTRODUCTION
Significance of Prostate Cancer
Approximately one in seven men in the United States will develop prostate cancer
(American Cancer Society, 2015), and prostate cancer will result in death among 3% of
those diagnosed (Violette & Saad, 2012). Prostate cancer is the number-one diagnosed
non-skin cancer and one of the largest causes of mortality among men of all ethnicities in
the United States (U.S. Cancer Statistics Working Group, 2014). Furlow (2012) reported
the median age for diagnosis of prostate cancer in the United States is 67years old, and
the median age of prostate cancer mortality is 80 years old. Approximately 220,800 new
cases and 27,540 deaths related to prostate cancer are estimated for 2015 (American
Cancer Society, 2015). Specifically, Wray and colleagues (2009) reported local or
regional prostate cancer is diagnosed in more than 90% of cases.
The five-year survival rate approaches 100% if prostate cancer is detected in the
localized stage (Wray et al., 2009). However, the five-year survival rate is only 31% if
prostate cancer is detected once it has metastasized (Jemal, Siegel, Xu, & Ward, 2010).
This contrast demonstrates the importance of detecting cancer in early stages and how the
prediction of survival is closely linked to the stage of cancer at time of diagnosis.
Significance of Culture
Culture encompasses customs, beliefs, knowledge, morals, and other capabilities
one possesses as part of society (Sobo, 2009). Acculturation was defined by Odedina and
colleagues (2011) as the degree to which individuals from a non-dominant culture learn a
host’s dominant culture, including lifestyles, behaviors, languages, and values. Kumar,
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Yu, Akinremi, and Odedina (2009) explained acculturation as not only learning another
culture, but also adapting to that culture. Kumar and colleagues (2009) reported
behavioral factors acquired from one’s culture have at times even overpowered genetic
risk factors for developing prostate cancer, so cultural factors are important to study in
relation to prostate cancer. This was the case for men of African descent living in various
locations throughout the world, who were studied by Kumar and colleagues (2009). The
researchers reported African American men had significantly higher incidence and
mortality rates from prostate cancer than West African men. Additionally, African
American men had a 3.5 times higher mortality rate and a 10 times elevated incidence
rate than Nigerian men (Kumar et al., 2009).
Furthermore, environmental modifiable factors from one’s culture or from
acculturation affect prostate cancer risk (Kumar et al., 2009). Modifiable risk factors
include dietary intake and physical activity (Kumar et al., 2009; Odedina et al., 2011).
Kumar and colleagues (2009) compared Nigerian men (n = 121) who had immigrated to
the United States (Texas) with indigent Nigerian men (n = 128) aged 35-79 using a crosssectional design, including interviews and questionnaires. The researchers found
Nigerian immigrant men had significantly more hours of purposeful physical activity and
dietary intake of whole grains and fruit, which could decrease prostate cancer risk.
However, Nigerian immigrant men also had reported higher intake of alcohol, oils, and
meats, which could increase prostate cancer risk. Kumar and colleagues (2009)
concluded acculturation and adaptation to Western culture in the United States (i.e.,
affordability and accessibility of food and alcohol) produced differences among reported
modifiable factors.
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Culture, according to Leininger (2002), is influenced by other factors besides
acculturation, including communication, religion, ethnicity, and economics. Sobo (2009)
found the meaning of words related to health care varied among cultures. At times, these
differences led to misunderstanding and potential communication barriers with health
care providers, which could in turn influence both the health actions taken, as well as the
use of the health care system and its resources (Sobo, 2009).
Low knowledge levels, insufficient communication, high mortality rates, and
socio-cultural factors influence prostate cancer screening practices among African
American men (Wray et al., 2009). Friedman, Corwin, Dominick, and Rose (2009) used
two health literacy tools to assess literacy and word choice in a sample of 25 African
American men from South Carolina aged 45 and older. The researchers used interviews
and discussion groups to study cultural communication and perceived barriers to prostate
cancer screening. Informed decisions were observed when the material was furnished
according to a man’s age and language (Friedman et al., 2009).
The application of the Culture Care Diversity and Universality Theory developed
by Leininger (2002) helped provide a framework for health care professionals to more
accurately communicate with patients and clarify health beliefs. Also, Friedman and
colleagues (2009) noted it was necessary to diminish the belief that cancer is “taboo”
among African American men to discuss and to correct misperceptions concerning risks
for prostate cancer. Some strategies to enact these changes included the development of
culturally relevant messages and the use of multiple communication modalities, including
mass media and word of mouth (Friedman et al., 2009). Furthermore, African American
men participated in informed decision making concerning prostate cancer screening to a
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greater extent when educational materials were culturally appropriate and when men
were guided through available options (McFall et al., 2009; Smith, Cokkinides, &
Brawley, 2012; Wolf et al., 2010).
Religion is a key component of culture (Leininger, 2002). The use of spiritually
based research programs was a culturally appropriate educational strategy implemented
among African American men in churches (Holt et al., 2009). Christian churches have
been found to be productive settings for conducting research among African American
men (Drake, Shelton, Gilligan, & Allen, 2010; Holt et al., 2009; Jackson, Owens,
Friedman, & Hebert, 2014; Parchment, 2004) and Afro-Caribbean American men
(Parchment, 2004).
Ethnicity is an aspect of culture that involves a shared origin one has with others
(Sobo, 2009). The number of men diagnosed with prostate cancer varies among
ethnicities (Roth, 2010), and men of African descent have an even higher mortality rate
than other men (Kumar et al., 2009). Specifically, “Black” men have a 60% higher
incidence rate of prostate cancer than non-Hispanic White men and more than twice as
large a mortality rate than any other ethnic group (American Cancer Society, 2015).
Furthermore, men of African descent, including African American and Afro-Caribbean
American men, have more aggressive prostate cancer, are 3 times more likely to be
diagnosed, are diagnosed in later stages of the disease, have higher prostate-specific
antigen (PSA) levels, and have earlier onset of the disease (Anderson, Marshall-Lucette,
& Webb, 2013). Men from Tobago and Jamaica have a reported incidence rate even
higher than African American men (Parchment, 2004). According to the American
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Cancer Society (2015), men of African descent have the highest incidence rates of
prostate cancer throughout the world.
Prostate cancer is the fifth overall cause of death and accounts for 11.1% of
deaths from any type of cancer in African American men (Carter, Tippett, Anderson, &
Tameru, 2010). Carter and colleagues (2010) conducted the above-mentioned study
among 76 African American men aged 45 and older in rural Alabama. Nelson, Balk, and
Roth (2010) also reported African American men are diagnosed at younger ages from an
archival research study in a sample of 55 African American men with a mean age of 63.
McFall and colleagues (2009) used cluster analysis and multidimensional scaling to
create concept maps in a sample of 16 Hispanic and 15 African American men. The
researchers found African American men have more disease symptoms and advanced
stages of prostate cancer at the time of diagnosis (McFall et al., 2009).
Odedina and colleagues (2011) reported Black men born in the United States
versus those born in the Caribbean or in Africa had different health behaviors and healthrelated customs concerning prostate cancer. In a sample of 2,864 men aged 40-70 labeled
Black from five cities in Florida, men of African descent born in Africa discussed early
detection and risk-reduction strategies concerning prostate cancer with a physician more
often than men of African descent born either in the United States or in the Caribbean
(Odedina et al., 2011). These findings were from self-administered surveys distributed at
ethnic barbershops, meetings at faith-based organizations, or ethnic events.
Several factors contribute to the disparities noted between incidence and mortality
rates for prostate cancer among African American men, including complementary and
alternative medicine practices, nutrition, lack of trust in the medical system, lower
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education, health experiences from the past, poverty, poor screening habits, and family
history of cancer (Jones, Steeves, & Williams, 2010). These factors were reported by 17
African American men aged 40-71 via interviews in a qualitative study by Jones and
colleagues (2010) conducted in rural Virginia. Furthermore, African American men
participating in a study using focus group data collection perceived a history of unequal
quality of medical treatment and decreased access to care throughout the history of the
United States, thus partially explaining the disparities in mortality, incidence, and
advanced disease among African American men with regard to prostate cancer (Wray et
al., 2009).
Healthy People is a national program of the United States Department of Health
and Human Services that sets goals in health promotion and disease prevention, focusing
on various health topics every 10 years (U.S. Department of Health and Human Services,
2014). Black men in the state of Florida was the only ethnic group that did not meet the
Healthy People 2010 prostate cancer goal of a mortality rate less than 28.8 per 100,000
men (Odedina et al., 2011). Since the likelihood of mortality decreases as localized
early-stage prostate cancer is detected via screening participation (van Leeuwen et al.,
2010), the above-noted high mortality rate disparity among Black men in Florida needs to
be addressed. Odedina and colleagues (2011) found various factors influenced men’s
involvement in prostate cancer screening: behavioral control, knowledge, attitude,
perceived susceptibility, and acculturation. Culturally appropriate strategies regarding
education and interventions to promote screening should be used to help diminish this
disparity regarding prostate cancer (Holt et al., 2009).
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The cost of treating prostate cancer is also significant. Patients and their loved
ones have a cost of burden in regards to emotional, spiritual, physical, and social needs
(Centers for Disease Control, 2011). Research is critical in order to increase prostate
cancer knowledge and screening behavior, thereby reducing the cost of treatment by
identifying cancer in earlier, more easily treatable stages (Aubry, Lieberthal, Willis,
Bagley, & Layton, 2013).
Prostate cancer had an overall direct cost of approximately $12 billion in 2010 in
the United States (Mariotto, Yabroff, Shao, Feuer, & Brown, 2011). In 2020, they
estimate the overall direct cost may be as much as $19 billion. Approximately $7 billion
is spent annually on over two million prostate cancer survivors (Skolarus, Zhang, &
Hollenbeck, 2012). The cost of prostate cancer treatment alone each year is greater than
$4 billion, and by 2019, it is predicted to be $8.7 billion (Aubry et al., 2013).
Study Purpose
The purpose of this study was to assess the likelihood of action for and factors
influencing choice regarding prostate cancer screenings. It was also to discover if a
relationship existed between ethnicity (African American and Afro-Caribbean American
men) and knowledge of prostate health, self-efficacy (measured by men’s level of
conflict in making an informed decision regarding prostate screening), perceived barriers
to prostate screening, and beliefs (measured by spiritual well-being). The results were
compared between African American and Afro-Caribbean American men, and
differences and similarities were examined.
This study was conducted in a sample of African American and Afro-Caribbean
American men. The men were from churches in South Florida that are part of the
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Congregational Health Alliance Ministry Program (CHAMP). The aforementioned
CHAMP is a partnership with Baptist Health System of South Florida and several
churches involved in the physical, spiritual, social, and emotional health and well-being
of members in the community.
Research Questions
Three research questions were asked in order to accomplish the study purpose.
The research questions were: 1) Is there a relationship between ethnicity (African
American and Afro-Caribbean American men) and level of prostate health knowledge?
2) Is there a relationship between ethnicity (African American and Afro-Caribbean
American men) and self-efficacy (measured by men’s level of conflict in making an
informed decision regarding prostate screening)? and 3) Is there a relationship between
ethnicity (African American and Afro-Caribbean American men) and influencing factors
on prostate screening behavior, including perceived barriers to screening and beliefs
measured by spiritual well-being?
Conceptual Framework
The Health Belief Model (HBM) was the theoretical framework that guided this
study. Rosenstock (1966) developed the model while he worked for the United States
Public Health Service with the hope of studying and promoting healthy behavior and the
use of health services. The original theoretical constructs of the model included
perceived susceptibility, perceived severity, perceived barriers, and perceived benefits
(Rosenstock, 1966). The constructs of perceptions and knowledge related to participation
in health behavior and services were added to the model in the 1970s and 80s
(Rosenstock, Strecher, & Becker, 1988). Other contributing theoretical constructs and
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modifying variables were later added to the model and included perceived cost, selfefficacy, perceived control, perceived threat, cues to action, health motivation, sociopsychological variables, and demographic variables (Rosenstock et al., 1988).
Rosenstock and colleagues (1988) reported the likelihood of action, as expressed
in the HBM, was affected by a modifying variable of ethnicity (i.e., culture).
Additionally, that same modifying variable influenced knowledge, attitudes, and
behaviors (Rosenstock et al., 1988). This study compared these same factors of
knowledge, attitudes (barriers and beliefs), and behaviors (decisional conflict or selfefficacy) with a modifying variable of ethnicity between African American and AfroCaribbean American men.
A person will take a health-related action, according to the HBM, if three main
components are present: the person feels a negative health condition can be avoided, the
person believes if a recommended action is taken the negative health condition can be
avoided, and the person believes he/she can take action with favorable outcomes (Janz &
Becker, 1984). Another main objective of the HBM is to explain beliefs and attitudes
that impact adherence to suggested medical care and participation in preventative health
measures (Dossey & Keegan, 2009). The HBM expresses how expectations (belief and
knowledge), perception of threat, and cues to action (internal and external motivators)
affect one another (Rosenstock et al., 1988).
In an intervention study, participants who had higher perception of risk and
knowledge had a significant increase in prostate cancer screening behavior (Emerson,
Reece, Levine, Hull, & Husaini, 2009). Emerson and colleagues (2009) conducted the
study among African American men (n = 152) aged 40-70 in 45 churches in Tennessee
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as a quasi-experimental, delayed-control (cross-over) design study with randomization at
the church level. The investigators used the HBM as a framework for the study.
Interviews were conducted by an African American man and self-reported questionnaires
were distributed regarding prostate cancer knowledge, attitudes, beliefs, and screening
behaviors. Data were collected at baseline and then at three-month and six-month
follow-ups after an hour-long educational intervention consisting of a 10-minute video
and a physician’s lecture and counseling (Emerson et al., 2009).
Furthermore, high perceived risk for cancer was related to an increase in healthseeking behavior for colon, breast, and prostate cancer screenings in a sample of 1,729
English-speaking men and women of various ethnicities aged 40 years and older from the
United States (Dillard, Couper, & Zikmund-Fisher, 2010). Dillard and colleagues (2010)
used random-digit dialed telephone surveys and the HBM as a framework for the study.
The researchers found among men with high-perceived risk, 35% sought screening versus
only 18% among those who had low-perceived risk. Additionally, self-administered
surveys were distributed by Odedina and colleagues (2011) among Black men, including
African American and Afro-Caribbean American men in Florida, aged 40-70, using the
HBM as a framework. Odedina and colleagues (2011) found perceived behavioral
control, knowledge, acculturation, perceived susceptibility, and attitude influenced
prostate cancer screening participation.
Study Variables for the Framework
The HBM was used in this study to help explain the preventative health behavior
of prostate cancer screening. Three theoretical constructs from the HBM, including
knowledge, self-efficacy (measured by decisional conflict), and perceived barriers, were
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examined in this study. These constructs were examined as dependent variables to the
independent variable of ethnicity, which is a fourth theoretical construct from the HBM
under the heading of modifying variables. Spiritual well-being, which is not a theoretical
construct of the HBM, was another dependent variable examined in connection with
ethnicity.
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CHAPTER II
REVIEW OF THE LITERATURE
The literature review was conducted via a search of electronic databases that
included Cumulative Index to Nursing and Allied Health Literature (CINAHL) and
PubMed. The search was limited to research reports in English from 2009 to 2015. The
key words used to identify related literature from CINAHL were ("Prostatic Neoplasms")
AND (MH "Cancer Screening") AND (consequence* OR importan* OR barrier* OR
obstacle* OR impact* OR value* OR cultur* OR belie*). "Prostatic Neoplasms"[Mesh]
OR “prostate cancer” OR “prostatic neoplasms” AND "Early Detection of
Cancer"[Mesh] OR Screen* OR “early detection of cancer” OR “Cancer Early
Diagnosis” OR “Cancer Early Detection” OR “Early Diagnosis of Cancer” AND "West
Indies"[Mesh] OR "African Continental Ancestry Group"[Mesh] OR "African
Americans"[Mesh] OR “Afro Caribbean” OR black* OR “African American” OR
Jamaica* OR Haiti* OR Trinidad* OR Tobago* OR “Caribbean black” OR “Caribbean
American” OR “West Indies” AND "Data Collection"[Mesh] OR
"Questionnaires"[Mesh] OR survey* OR questionnaire* OR “data collection” AND
"Patient Acceptance of Health Care"[Mesh] OR "Attitude to Health"[Mesh] OR "Health
Services Accessibility"[Mesh] OR “Health Knowledge, Attitudes, Practice"[Mesh] OR
consequence* OR importan* OR barrier* OR obstacle* OR impact* OR value* OR
belie* OR knowledge OR cost OR attitude* OR spiritual* OR “comfort level” OR
“Informed Decision Making” OR access* OR aware* were used for PubMed.
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Prevalence and Risk for Men of African Descent
The age-adjusted (a strategy to proportionally compare populations with different
age distributions) prostate cancer count during 2009-2011 in Florida was 40,824 and the
rate was 115.8 per 100,000 men, but Miami-Dade County had an even higher overall rate
of 127.8 per 100,000 men and a count of 4,929 (University of Miami (FL) Medical
School, Florida Cancer Data System, 2008-2011). The age-adjusted prostate cancer
count for Black men, including African American and Afro-Caribbean American men,
during 2008-2010 for Miami-Dade County was 1,086 and a rate of 195.8 per 100,000
men, as compared to “White” men with a rate of 119.3 per 100,000 men (University of
Miami (FL) Medical School, Florida Cancer Data System, 2008-2011). It was found to
be important to include Afro-Caribbean American men in studies among Black men in
South Florida because a large number of Afro-Caribbean American men have immigrated
to that part of the United States due to its similar climate and close proximity to the
Caribbean (Archibald, 2011).
The ethnic group labeled Black American men was reported as having low
prostate cancer survival rates, more late-stage prostate cancer diagnoses, incorrect
identification of early symptoms of prostate cancer, and a prostate cancer mortality rate
greater than 28.8 per 100,000 men in the state of Florida (Odedina et al., 2011). Odedina
and colleagues (2011) reported several reasons for prostate cancer disparities among
Black American men, including inadequate knowledge, lack of trust of the health care
system, lower socioeconomic status, and limited health care access. These researchers
collected data from 2,864 men aged 40-70 labeled Black, including African American
and Afro-Caribbean American men, in five cities in Florida.
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African American men specifically had higher mortality and incidence rates than
any other ethnic group (Lehto, Song, Stein, & Coleman-Burns 2010; Nelson et al., 2010).
Yet when compared with other ethnic groups, African American men also had a lower
perceived risk of being diagnosed with prostate cancer (Glenn et al., 2012). Glenn and
colleagues (2012) reported this finding from the study, which utilized telephone surveys
among first-degree relatives (n = 1,029) of men diagnosed with prostate cancer (354 nonLatino White, 228 Latino, 272 African American, and 175 Asian men). Additionally,
African American men exhibited low rates of participation in cancer research (Friedman
et al., 2012). The American Cancer Society (2015) suggested African American men
could be at a higher risk for prostate cancer diagnosis due to genetics, inherited
conditions, diet, and family history of prostate cancer.
Odedina and colleagues (2011) studied differences among men of African descent
born in the United States versus men born in Africa and born in the Caribbean.
Differences existed in early detection and risk-reduction behaviors related to prostate
cancer. Odedina and colleagues (2011) found Black men born in the United States had
the highest knowledge level regarding prostate health and were the most likely to have
health insurance, as compared to African-born and Caribbean-born Black men. Black
men born in Africa discussed prostate cancer risk reduction and early detection with a
health care provider the most (Odedina et al., 2011). In a study of 180 Black men,
Jamaican-born American men had higher prostate cancer anxiety than African American
men born in the United States (Consedine, 2012). In addition, men from Tobago and
Jamaica had a higher incidence rate than African American men (Parchment, 2004).
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However, Afro-Caribbean American men had similar findings as African
American men in several areas: both had more aggressive prostate cancer, were 3 times
more likely to be diagnosed, were diagnosed in later stages of the disease, had earlier
onset of the disease, had higher PSA levels, and had a 60% higher incidence rate than any
other ethnic group (Anderson et al., 2013). Men of African descent from Caribbean
countries, similar to African American men, also had over twice as high mortality rates
from prostate cancer (Ng et al., 2013). Furthermore, African American and AfroCaribbean American men (specifically subpopulations of immigrant Caribbean men) had
low rates of participation in PSA screenings (Lee, Consedine, Gonzalez, & Spencer,
2012). Ng and colleagues (2013) indicated more studies should be conducted among
Afro-Caribbean American men because not as many studies have been conducted as
among African American men.
Screening
Screening Properties
The major objective in screening for prostate cancer is to identify cancer in as
early a stage as possible because treatment in an early stage has been shown to decrease
both mortality and metastasis (van Leeuwen et al., 2010). Screening of prostate cancer is
most commonly done by a digital rectal exam (DRE) and a PSA test (Wong & Coups,
2011). A DRE is performed by a health care provider inserting a gloved, lubricated
finger into the rectum to palpate for abnormalities of the prostate (Wray et al., 2009).
The DREs have a wide specificity and sensitivity range, which could be explained in part
by the anatomical position and volume of the prostate gland (Koulikov, Mamber,
Fridmans, Arafeh, & Shenfeld, 2012). Also, Koulikov and colleagues (2012) concluded
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a DRE exam had a high inter-observer variability due to the subjective opinion and length
of finger of the health care provider. Furthermore, Ugwumba and Nnabugwu (2012)
reported the examiner needed to have performed several DREs in order to be proficient in
conducting a DRE, and supervision and models could enhance the ability of a new
examiner to conduct an accurate DRE.
The prostate gland’s epithelial cells produce an elevated level of the glycoprotein
PSA in the presence of prostate tissue damage. Richard Ablin invented the PSA test and
recommended that due to its low sensitivity and specificity for prostate cancer, the PSA
test should be used in conjunction with another screening modality, such as a DRE (Bul
& Schrööder, 2011). Testing for PSA levels was first approved for use in combination
with a DRE in men 50 years old or older to screen for prostate cancer by the United
States Food and Drug Administration in 1994 (Austin, 2012). Bul and Schrööder (2011)
conducted a non-systematic review of evidence both for and against prostate cancer
screening with a particular emphasis on three randomized screening trials. The
researchers concluded the ideal screening tool for prostate cancer did not exist. Such a
tool could be used by doctors to help doctors avoid misdiagnosing indolent cancers that
would never cause problems or symptoms, as well as detect harmful cancers in an early
and more easily treatable stage (Aubry et al., 2013; Bul & Schrööder, 2011). To improve
prostate cancer screening in the future, PSA tests may include PSA molecular biomarkers
or other forms of testing as well (Shariat et al., 2011).
According to Soydan and colleagues (2013), one way to avoid treating indolent
cancers was to use active surveillance, especially for men with low-risk prostate cancer.
During active surveillance, practitioners wait to observe any symptoms that arise or any
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drastic changes that occur between annual screenings in order to avoid unnecessary
treatment of benign prostatic conditions, instead of taking further action in response to a
high PSA level (Soydan et al., 2013). Active surveillance not only evades unnecessary
treatments, but active surveillance also detects higher risk prostate cancers that need to be
treated (Soydan et al., 2013). It is important for both practitioners and patients to
understand active surveillance incorporates regular examination of patients with low-risk
prostate cancer. Soydan and colleagues (2013) reported the screening examinations
involved in active surveillance are PSA-level measurements, DREs, and sometimes
image guided biopsies. Cooperberg, Carroll, and Klotz (2011) discovered two challenges
to the acceptance of active surveillance use by health care professionals and patients:
understanding what the end goals were for the surveillance and the risk of progression at
the time of diagnosis. When active surveillance was used among men diagnosed with
low-risk prostate cancer, cure rates did not change for men treated later as compared to
men who were treated initially after diagnosis (Cooperberg et al., 2011).
Why Screening is Important
Van Leeuwen and colleagues (2010) reported when PSA screenings were
conducted, prostate cancer metastasis was reduced by 53% and prostate cancer mortality
was decreased by 37% over the eight-and-one-half-year period of the study. In fact,
Wray and colleagues (2009) reported screening as the only strategy with a reasonable
reduction in prostate mortality. The ability to detect prostate cancer early and thus
decrease mortality risk demonstrates the importance of implementing prostate screenings
(Basch et al., 2012).
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A total of 51.1% of men 50 years old or older in the United States in 2010
reported participating in a PSA test and 55.4% had a DRE (Wong & Coups, 2011). Lack
of knowledge regarding prostate cancer and low rates of screening have been observed
across the United States among various ethnicities (Rivera-Ramos & Buki, 2011).
Screenings are participated in less when men have a low perceived risk of developing and
dying from prostate cancer (Shavers, Underwood, & Moser, 2009). The researchers
selected a sample of 1,075 using random-digit-dialing, which consisted of African
American, Hispanic, and Caucasian males aged 45 or older without any history of
prostate cancer. An analysis was conducted examining the association among perception
of risk of developing prostate cancer, demographic characteristics, and PSA test
utilization among the sample population using a multivariable logistic regression
analysis.
Shavers and colleagues (2009) found reasons for low screening rates included low
perceived personal risk for cancer diagnosis, the role race/ethnicity played on these
perceptions, how information was processed regarding statistical cancer risks, and
processing methods. The findings contributed to the body of knowledge on men’s
perception concerning prostate cancer risk and demonstrated that providing information
regarding risk of developing prostate cancer could aid all men, especially African
American men, in making a decision regarding prostate cancer screening (Shavers et al.,
2009). Furthermore, McFall and colleagues (2009), through the use of concept mapping,
found a high importance rating was necessary for informed decision making concerning
prostate cancer screening in African American men.

18

Screening Controversy
Prostate cancer screening using the PSA test has decreased the age of diagnosis
(Cross, Ritter, & Reding, 2012) and mortality rate and increased the early detection and
treatment of prostate cancer (van Leeuwen et al., 2010). However, a controversy exists
regarding PSA testing due to the over diagnosis and over treatment of indolent prostate
cancer (Bul & Schrööder, 2011). The controversy has been debated in the United States
and other countries for decades (Austin, 2012). The controversy mainly involves
investigating the bioethical issue of the benefits of screening versus the harms and
subsequent possible treatment and side effects (Davis et al., 2012).
The United States Preventive Services Task Force (USPSTF) does not
recommend mass prostate cancer screenings of the general male population. The
USPSTF’s report from 2011 concluded PSA screenings either did not reduce prostate
cancer mortality or only reduced mortality to a small degree, and PSA screenings resulted
in needless subsequent evaluation and treatments (Chou et al., 2011). The USPSTF also
concluded risks outweighed benefits with at least moderate confidence for men 75 years
or older. However, insufficient evidence was available to either recommend for or
against routine screening in men less than 75 years old (Howard, Tangka, Guy,
Ekwueme, & Lipscomb, 2013). Howard and colleagues (2013) noted 7.9% fewer PSA
tests were completed among men 75 years old or older over the two years following the
revised recommendation.
Because other non-cancer-related factors may contribute to high PSA levels,
insufficient evidence was available to recommend for or against PSA screening. Noncancer related factors include infection, inflammation, benign prostatic hyperplasia, and
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other benign states (Howard et al., 2013). Aubry and colleagues (2013) reported out of
the 1.3 million biopsies performed annually in the United States, 75% were negative.
Many men subsequently were subjected to an unnecessary invasive biopsy procedure
with its own inherent risks (Aubry et al., 2013).
In addition, Bell and Kazanjian (2011) reported prostate cancer progresses very
slowly, so most men did not experience serious symptoms or a premature death from the
disease. Davis and colleagues (2012) concluded some screenings have detected
insignificant prostate nodules and indolent prostate cancer. It was also reported surgeries
have been performed at times unnecessarily. Sometimes, side effects are needlessly
experienced in association with the treatment of prostate cancer: physiological
dysfunctions (i.e., urinary and bowel), sexual dysfunctions, and emotional dysfunctions
(Davis et al., 2012). A meta-analysis by Djulbegovic and colleagues (2010) and a
randomized screening trial by Sandblom, Varenhorst, Rosell, Lofman, and Carlsson
(2011) both failed to report a decrease in mortality with the implementation of PSA
screenings; therefore, both groups of researchers could not support or refute routine
prostate cancer screening.
Detractors of PSA testing point to over diagnosing and unnecessary procedures
(Ilic, Neuberger, Djulbegovic, & Dahm, 2013). Bul and Schrööder (2011) concluded
PSA measurements were not accurate to screen for prostate cancer; therefore, PSA
measurements were not to be used alone in the screening process. The researchers also
discovered even if the PSA level was low, sometimes a high-grade prostate cancer was
still present. Bul and Schrööder (2011) found approximately 50% of the men who were
identified as having prostate cancer, through prostate cancer screening, never experienced
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prostate cancer symptoms throughout life. Harms of participating in screening were
reported as over diagnosis and overtreatment of false positive PSA results and negative
effects from biopsies, including pain, bleeding, and infection (Ilic et al., 2013).
However, supporters of PSA testing pointed to other research that showed
screening for prostate cancer had the potential to prevent mortality and metastasis. For
example, participating in PSA screening reduced prostate cancer metastasis by 53% and
prostate cancer mortality by 37% during a study period of eight and one-half years (van
Leeuwen et al., 2010). Likewise, Bul and Schrööder (2011) found screening decreased
mortality at a nine-year follow-up by 20-31% and 44-56% at a 14-year follow-up in the
Göteborg screening trial in the European Randomized Study of Screening for Prostate
Cancer, which was a trial involving seven countries and over 180,000 men.
For men at risk for prostate cancer, the American Urological Association (AUA)
recommends routine screening with a PSA test and a DRE (Aubry et al., 2013). The
AUA firmly supports this recommendation because screenings have assisted in the
diagnosis of early low-stage cancers. Without PSA and DRE routine screenings, the
AUA reports prostate cancer will have increased cost for treatment, side effects, burden
from the disease, and aggressive treatments for high-risk, late-stage cancers (Aubry et al.,
2013). Early detection from screenings decreased treatment costs and increased curative
rates in a study by Skolarus and colleagues (2012). Increased early low-stage cancer
diagnosis of the disease was a main benefit from prostate cancer screenings (Eldefrawy,
Katkoori, Abramowitz, Soloway, & Manoharan, 2013). Since the implementation of
prostate cancer screenings, mortality rates from prostate cancer have decreased
(McCormick, Osman, & Pomerantz, 2010).
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Evidence exists for both detractors and supporters of routine prostate cancer
screening among the general male population in the United States, as well as specific
recommendations for certain groups of men. For example, Basch and colleagues (2012)
suggested men with less than a 10-year life expectancy not be encouraged to participate
in a PSA test due to the risk of a false positive, subsequent biopsy, and unnecessary
treatment. The American Cancer Society (2015) also recommended men who are not
expected to live at least 10 years not be screened because prostate cancer spreads so
gradually. However, men who have a greater than 10-year life expectancy were
encouraged to discuss with health care providers the benefits and harms of PSA testing,
starting at age 50, if they are at average risk for prostate cancer (American Cancer
Society, 2015).
Other specific screening recommendations were made for men with relatives with
prostate cancer by McDowell, Occhipinti, Gardiner, Baade, and Steginga (2009). The
researchers found family history of cancer does not only increase risk of cancer in men of
African descent, but in all men. The risk of a first-degree relative of a man with prostate
cancer being diagnosed with prostate cancer was more than twice that of the general
population, and the risk was 3 times greater if more than one first-degree relative was
diagnosed with prostate cancer. An increased risk was also noted if the relative was less
than age 60 when he was diagnosed (McDowell et al., 2009).
In light of these increased risks, the American Cancer Society (2015)
recommended discussing risks and benefits concerning screening at age 45 for African
American males or for men with a first-degree relative with an early age (less than 65
years old) diagnosis of prostate cancer, and at age 40 for men with multiple first-degree
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relatives diagnosed with prostate cancer at an early age. After this discussion, if a man
decided to participate in screening, the American Cancer Society (2015) recommended a
PSA test be completed either alone or with a DRE. If a man was unable to decide, it was
suggested the health care provider make the decision of screening or not based on the
patient’s values and health preferences. If, after testing, the PSA was less than 2.5 ng/ml,
rescreening was not necessary for two years; and if greater than 2.5 ng/ml, rescreening
was recommended annually (American Cancer Society, 2015). Because men of African
descent had higher rates of both diagnosis of and mortality from prostate cancer, it was
recommended screening be done early and frequently for possible diagnosis and
treatment (American Cancer Society, 2015).
The consensus on the screening controversy was that a PSA test should not be
used alone for screening, but should be used in conjunction with a DRE for more accurate
results (Smith et al., 2012; Vickers, Roobol, & Lilja, 2012). Also, it was agreed upon
that prostate cancer screenings should incorporate men participating in an informed
decision-making process with health care providers (American Cancer Society, 2015).
Informed decision making involved two main parts: 1) obtaining information regarding
risks, benefits, alternatives, and uncertainties regarding prostate cancer from a health care
provider and culturally reliable and appropriate resources and 2) making the decision
according to the man’s values and preferences (Davis et al., 2012). Ferrante, Shaw, and
Scott (2011) found shared decision making was a method used by providers to instruct
men concerning benefits, possible harms, limitations, and risks of prostate cancer and
screenings, and then to help men make a choice based on these issues and a man’s
beliefs, values, and desires. Additionally, Ferrant and colleagues (2011) found informing
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men of the benefits and limitations of prostate cancer screening was a more effective
means to promote and facilitate shared decision making in regards to screening.
Perceived Barriers to Screenings
Even though screenings have decreased prostate cancer metastasis and mortality
(van Leeuwen et al., 2010), several barriers have been found to decrease men’s
participation in prostate cancer screenings. The impediments to health-seeking behaviors
with respect to prostate cancer screenings were significant. Different barriers were noted
among racial groups.
Some barriers specific to African American men included low knowledge,
understanding, and information regarding prostate cancer screenings, such as a
misunderstanding between diagnostic tests and screening (Friedman et al., 2009). Lack
of trust in the health care system, deficient communication with health care providers,
inconvenient clinic hours, limited access to health care services, and lack of health
insurance were also common barriers reported by African American men (Friedman et
al., 2009). Friedman and colleagues (2009) used two health literacy tools in a sample of
25 African American men from South Carolina aged 45 and older and found the men had
adequate health literacy levels. The authors concluded health literacy levels among
African American men were not found to influence screenings. However, the men were
not able to articulate prostate cancer risk factors and preventive behaviors during
interviews and discussion groups. Friedman and colleagues (2009) suggested that, in the
future, prostate cancer information be presented without extensive medical jargon but
with culturally appropriate messages to help African American men understand the
information more completely, regardless of what the health literacy scores showed.
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Emerson and colleagues (2009) conducted a study utilizing interviews and selfreported questionnaires in churches among 152 African American men aged 40-70 and
found a significant barrier to screening was deficient knowledge of where to access
affordable treatment if cancer was found. Likewise, Oliver, Grindel, DeCoster, Ford, and
Martin (2011) reported in a sample consisting of predominantly African American men,
other barriers were: the screening taking too much time at 87.1%, embarrassment at
74.2%, lack of understanding of the screening process at 68.7%, and fear of pain related
to the screening at 66%.
Wray and colleagues (2009) reported African American men had the barrier of
decreased trust in the health care system, which stems from unequal quality of care and
limited access to care among African Americans. The researchers conducted five focus
groups (four with healthy men and one with prostate cancer survivors) among African
American men, led semi-structured interviews with 19 community leaders, and evaluated
two outreach projects involving survivors in which they discussed prostate cancer and
screening with African American men. The researchers reported barriers to prostate
cancer screening and treatment among African American men in three main levels (Wray
et al., 2009). The first was at the individual level, with fear of prostate cancer and
deficient knowledge of prevention, the condition, and treatment. The second was at the
socio-cultural level, which consisted of such obstacles as unwillingness to discuss cancer,
lack of a provider to perform preventive and routine care, dislike of screening, and lack
of trust of the medical system. The third was at the institutional level, with insufficient
educational programs focused on prostate cancer.
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Barriers specific to Afro-Caribbean American men were gender-related
perceptions, concerns for privacy, time away from work, limited access to care, and
ineffective dissemination of health information (Ng et al., 2013). These barriers to
health-seeking behaviors, including participation in prostate cancer screenings, were
discovered after completing key informant interviews among 30 African Barbadian men,
wives of Barbadian men, health care providers, and community and religious leaders.
Additionally, fear was a screening barrier Kleier (2010) reported via surveys in a sample
of 143 Afro-Caribbean (Haitian) American men.
In-depth, face-to-face interviews were conducted by Anderson and colleagues
(2013) with seven Afro-Caribbean men in the United Kingdom, and four major themes in
regards to prostate cancer awareness, barriers, and screening beliefs were identified:
disease-prompted awareness, checking up as a necessary evil, defining and constructing
factors influencing prostate cancer screening, and appraising perceived myths of prostate
cancer. These four major themes helped explain Afro-Caribbean men’s perspectives of
prostate cancer awareness, barriers to screening, factors influencing screening beliefs,
and fears of the disease. The authors noted professional background and education
influenced the level of awareness of prostate cancer and willingness to seek help. The
authors also found specific health education strategies targeting the Afro-Caribbean
population could encourage men to seek prostate health assistance earlier.
Studies were also conducted with both African American and Afro-Caribbean
American men in regards to prostate cancer screening barriers. In a study involving
2,864 men aged 40-70 of African descent, Odedina and colleagues (2009) found
inadequate knowledge of prostate cancer disease and screening, lower socioeconomic
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status, and incorrectly identified early symptoms of prostate cancer were barriers to
screening. Additionally, prostate cancer screening participation was influenced by
perceived behavioral control, acculturation, perceived susceptibility, and attitude
(Odedina et al., 2011).
Lee and colleagues (2012) indicated African American and Afro-Caribbean
American men from Jamaica and Trinidad participated less in DRE screenings, even after
adjusting for comorbidities, access to care, and socioeconomic status, and had
significantly higher levels of health care system barriers. These barriers included greater
prostate cancer worry, fear of screening, and difficulty navigating the health care system.
Barriers to screening from men of African descent, including Afro-Caribbean American
men from Jamaica, Bahamas, Trinidad, Haiti, and Guyana, were embarrassment to have a
DRE and fear of impotence and incontinence if diagnosed with and treated for prostate
cancer (Parchment, 2004).
Pedersen, Armes, and Ream (2012) conducted a systematic review of 13
qualitative studies and 20 cross-sectional surveys to discover the factors influencing
prostate cancer participation among African American and Afro-Caribbean American
men. Awareness of the personal risk for prostate cancer was not consistent among the
studies. Mistrust of the health care system, limited access to health care, lack of trusting
relationships with health professionals, misunderstanding regarding methods of diagnosis
and treatment, and feeling a threat to a man’s sense of masculinity were common barriers.
Researchers should be aware of reported perceived barriers when communicating prostate
health and screening information with African American and Afro-Caribbean American
men to decrease these barriers (Pedersen et al., 2012).
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Methods have been studied to reduce prostate cancer screening barriers among
men of various ethnicities. Increasing perceived risk of prostate cancer, participating in
making decisions, and educating men regarding prostate cancer were methods to
overcome barriers (Dillard et al., 2010). Dillard and colleagues (2010) found these
methods by conducting telephone surveys among 1,729 English-speaking men and
women aged 40 years old and older of various ethnicities from the United States.
Other methods to reduce prostate cancer screening barriers among African
American men have been discovered as well. Wray and colleagues (2009) collected
evaluations from African American men and found a successful way to increase prostate
cancer knowledge, promote conversations centered on prostate cancer, and encourage
men to engage in screenings was having survivors lead outreach projects among African
American men. Similarly, Mitchell (2011) found from a survey distributed at a
community health fair among 229 African American men 18 years old or older higher
educational levels, access to a health care provider on a regular basis, and older age were
all associated with increased rates of prostate cancer screening. Additionally, greater
access to care, education, insurance coverage, knowledge, and community involvement
increased the number of African American men who completed health screenings and
increased the perception of risk for prostate cancer (Emerson et al., 2009).
Furthermore, prostate cancer screening barriers among African American men
were reduced when perceived risk of prostate cancer diagnosis was increased. Lehto and
colleagues (2010) reported a correlation between perceived risk of prostate cancer and
increased participation in screenings. The findings were from a study of African
American men (n = 60) aged 38 to 79 recruited from churches in the greater Detroit
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metropolitan area. The self-administered survey results revealed health values and age
were the two most predictive variables impacting prostate cancer screening among
African American males (Lehto et al., 2010). Also, Lehto and colleagues (2010)
concluded educational interventions focused on health values and screening interventions
should be aimed at younger African American males. Shavers and colleagues (2009)
reported men who had a lower perceived risk of the disease were less willing to
participate in prostate cancer screenings, and African American men often perceived
prostate cancer diagnosis risk less than the average man the same age. Shavers and
colleagues (2009) conducted the study among African American, Hispanic, and nonHispanic White (n = 1,075) men aged 45 or older, who responded to the 2003 Health
Information National Trends Study (HINTS).
Culture
Importance of Culture in Research
Cultural issues are complex and need to be addressed in research to improve the
health care system (Sobo, 2009). Economic, political, and social factors were noted to be
interconnected with cultural issues. For example, the economical concern of cost has
been observed to be related to cultural understanding of the health care system. Cost of
treatment for prostate cancer was reduced as knowledge of prostate health and screening
behavior increased (Aubry et al., 2013). Also, the Patient Protection and Affordable Care
Act is a political aspect of culture that has expanded health insurance coverage to
millions of Americans and made it possible for increased access to and understanding of
the health care system (Andrews, Darnell, Mcbride, & Gehlert, 2013). Additionally,
social support, a social component of culture, was reported by Jones and colleagues
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(2010) to increase informed decision making regarding prostate screenings in the health
care system. Furthermore, Sobo (2009) reported meanings of words or semantics varied
among cultures regarding health care, illness, and well-being. These differences could
cause miscommunication and misunderstanding, which could affect how resources were
used and actions were made. Additionally, culturally appropriate communication was
essential for culturally competent care (Sobo, 2009).
The concept of cultural competence includes providing care that is not only
culturally responsive, effective, and relevant, but also improves health outcomes and
decreases ethnic and racial disparities (Shen, 2015). Cultural competence is one cultural
issue that has been extensively studied in nursing over the past 30 years, and various
models and instruments have been developed to measure cultural competence (Shen,
2015). Cross, Bazron, Dennis, and Isaacs (1989) first used the term cultural competence
in published literature as, “a set of congruent behaviors, attitudes, and policies that come
together in a system, agency, or amongst professionals and enable that system, agency, or
those professionals to work effectively in cross-cultural situations” (p. 7).
Culturally congruent care (often referred to as cultural competence) for nursing
was defined by Leininger (2002) to include religion, economics, language, history,
worldview, gender, practices, meanings, values, environment, symbols, politics, and
expressions. Leininger (2002) was the first to study culturally congruent care connecting
nursing with anthropology and developed the Culture Care Diversity and Universality
Theory, the use of transcultural nursing practice, and the use of ethnonursing research.
The theory was culturally specific, but also was broad and applicable to various cultures
on health, death, illness, and well-being for groups and individuals (Leininger, 2002).
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Leininger’s (2002) goal for the theory was to develop safe, meaningful, and culturally
congruent care for both diverse and similar cultures based on research. The application
of the theory caused improvements to the health care system, such as more accurate
communication between patients and health care professionals (Leininger, 2002). Shen
(2015) reported that the cultural, racial, and ethnic diversity in the United States has
sparked a need for a variety of culturally competent models in nursing to be developed
and promoted. Cultural competency has increased understanding, awareness, and
sensitivity of various cultures among nurses and other health care providers during
interactions with patients and has increased the ability to provide quality competent care
(Shen, 2015).
Culturally Appropriate Strategies
Miller (2014) stressed additional culturally tailored outreach efforts needed to be
made and further research needed to be conducted in order to understand knowledge,
attitudes, and behaviors in terms of prostate cancer screening among African American
men. Those conclusions were drawn after a study was completed among 46 African
American men aged 30-45 from urban Ohio. Culturally appropriate strategies to help
diminish disparities in men’s health were of even greater importance with African
American men than with other ethnic groups (Holt et al., 2009). A successful educational
method concerning prostate health was using culturally appropriate strategies with
African American men from a study conducted at two Baptist churches in Alabama
among 49 African American men aged 45 or older (Holt et al., 2009). Two main
components needed to increase the number of African American men completing health
screenings were education and community involvement (Emerson et al., 2009).
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Making the educational materials culturally appropriate and the manner in which
those materials were presented were also important strategies. Drake and colleagues
(2010) noted a significant improvement (p = 0.025) in African American men’s ability to
make informed decisions regarding early detection for prostate cancer when accurate and
meaningful information was received from an educational church-based intervention
among predominantly African American men (n = 73). Making educational material
culturally appropriate helped African American men comprehend screening options and
make informed decisions regarding prostate cancer (McFall et al., 2009; Smith et al.,
2012; Wolf et al., 2010). An increased number of informed decisions regarding prostate
cancer screening were demonstrated by African American men when material was
accommodated to a man’s language and age (Friedman et al., 2009). Archibald (2011)
found culturally appropriate strategies specifically for Afro-Caribbean American men
through a content analysis. Among Afro-Caribbean American men, strategies should
focus on the men’s healthy intentions, appropriate attitudes, and strong values. These
three elements were reported as necessary components to consider when developing an
intervention for this population (Archibald, 2011).
Another culturally appropriate strategy was changing the setting of prostate
education from a clinical one to a community one (Drake et al., 2010). In fact, Drake and
colleagues (2010) completed an educational church-based intervention among 73 men
who were predominantly African American and reported churches were successful
community settings for educating African American men regarding prostate cancer
knowledge and screening. Using community involvement, especially using churches as
settings, has opened new doors for African American men to be educated and receive
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health care in settings other than the traditional, clinical ones (Jackson et al., 2014).
Saunders and colleagues (2013) concluded the majority of African American men were
highly involved in churches, so churches appeared to be good settings for conducting
research in this population. Christian churches have proven successful locations for
surveying and educating African American men (Holt et al., 2009; Jackson et al., 2014;
Parchment, 2004) and Afro-Caribbean American men (Parchment, 2004) regarding
health issues and practices in other studies as well.
Prostate Cancer Cost
The overall cancer cost in 2010 in the United States was estimated by the Centers
for Disease Control (2011) as a combination of lost productivity and medical costs at
$263.8 billion. Furthermore, Mariotto and colleagues (2011) reported prostate cancer had
a direct cost of $12 billion in 2010 in the United States. They estimated the direct cost
may increase to $19 billion in 2020. Negative effects on quality of life were reported as
indirect costs related to prostate cancer (Aubry et al., 2013). The annual cost of prostate
cancer treatment in 2019 was predicted to be $8.7 billion (Aubry et al., 2013). Eldefrawy
and colleagues (2013) reported prostate cancer cost increased in recent years in the
United States due to earlier detection, higher incidence, and longer life expectancy.
Aubry and colleagues (2013) listed screening cost as one component of prostate
cancer cost. The risk of a false positive result from a PSA test was an additional cost
(McCormick et al., 2010). Annually, 19 million men were screened for prostate cancer
using PSA levels in the United States with an estimated cost of $1.86 billion (Aubry et
al., 2013). Also, from these 19 million men screened, it was observed 4.7 million had
abnormal PSA results (≥4.0 ng/mL).

33

The Patient Protection and Affordable Care Act does not guarantee all people
qualify for the same preventive services, including prostate cancer screenings (Wilensky
& Gray, 2013). However, Congress has developed some requirements for Medicare,
Medicaid, and private insurers under the Patient Protection and Affordable Care Act to
waive the coinsurance and deductible payment through the Social Security Act for PSA
screenings but not for DRE screenings (Stranne, 2011). Another aim of the Patient
Protection and Affordable Care Act was to make insurance more affordable and in turn
decrease the number of uninsured in America (Giaimo, 2013). The Act expanded
coverage to approximately 30 million Americans (Andrews et al., 2013). Goldenberg
(2013) predicted that by 2019, a total of 17 million Americans below the poverty line
would be eligible for Medicaid and receive improved access to wellness visits and free
preventative care, including prostate cancer screenings on all insurance plans. Just as
people do not always take advantage of Medicaid when it is available, men frequently did
not take advantage of prostate screening even when screenings were free (Gash &
McIntosh, 2013).
Aubry and colleagues (2013) noted another cost was from the conducting of
biopsies, which were invasive and possibly harmful. Aubry and colleagues (2013)
reported 1.3 million biopsies (one biopsy was defined as one biopsy session, which
included 10 to 12 needle core tissue samples) were performed annually. The researchers
found 75% of men had negative biopsies, and multiple biopsies increased a patient’s risk
of infection, hypotension, sepsis, discomfort, cystitis, endocarditis, prostatitis, urinary
symptoms (including hematuria), antibiotic resistance, and gastrointestinal hemorrhage.
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Prostate cancer treatment choice also affects cost. Eldefrawy and colleagues
(2013) conducted a comparison of different treatment options for prostate cancer of the
cumulative medical costs for open radical retropubic prostatectomy, robotic-assisted
radical prostatectomy, external beam radiotherapy, brachytherapy, and active
surveillance. Active surveillance had a low initial cost, was the overall most costeffective choice, and had the lowest follow-up cost in treatment of low-grade prostate
cancer. Active surveillance was found to reduce treatment interventions for prostate
cancer; therefore, it was found to decrease treatment complications and the effects on
quality of life. Also, when outpatient centers were used for active surveillance, the costs
from lost days from work, including loss of wages and decreased productivity and use of
inpatient facilities, were reported to be minimal (Eldefrawy et al., 2013).
Bul and Schrööder (2011) suggested several factors needed to be combined to
assess the value of prostate cancer screening. Additionally, the authors reported benefits,
costs, and QALYs were components that should all be compared to understand the
possible reduction in prostate cancer mortality by men participating in screenings. In
addition, various treatment options exist that differ in price, subsequent QALYs, and
costs and benefits for the patient (Nguyen et al., 2011). Not only was the patient affected,
but his friends, caregivers, and family members also had a cost of emotional, spiritual,
physical, and social burden placed on them (Centers for Disease Control, 2011). Indeed,
cancer cost is calculated not only in a dollar amount, but in burden and effects on quality
of life.
Some symptoms that affected quality of life included erectile dysfunction, hot
flashes, loss of muscle mass, urinary incontinence, induced metabolic syndrome, loss of
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bone, and even cognitive impairment (McDowell et al., 2009). Bungay and Cappello
(2009) reported urinary symptoms, such as incontinence and increased frequency, were
very common because of prostate cancer itself and subsequent treatment. Additionally,
increased frequency of urination at night and night sweats disrupted many men’s sleep
and led to men feeling fatigued. Moreover, men often needed to make lifestyle changes
by planning trips around bathroom facilities and decreasing water intake, especially at
night (Bungay & Cappello, 2009). Rivers and colleagues (2010) reported quality of life
related to sexual dysfunction was the highest concern for men diagnosed with prostate
cancer, which was an even higher concern than survival from the disease.
Eldefrawy and colleagues (2013) discovered a large burden is placed on the
United States health care system because prostate cancer is so prevalent. As the United
States attempts to decrease unnecessary medical costs, it is important to know how much
money has been spent in the past and who has been paying for health care. The majority
of the health care money in the United States was spent on hospital services as an
inpatient (33%) and physician services as an outpatient (23%) (Eldefrawy et al., 2013).
The authors reported the government accounts for 45% of the cost, employer 36%, and
patients 15%. Wray and colleagues (2009) reported a five-year survival rate of almost
100% when prostate cancer was diagnosed in the localized stage. Not only could men
live longer, but money could also be saved by the patients, insurance companies, and
employers if screening for prostate cancer was completed and cancer was identified early
in more easily treatable stages (Aubry et al., 2013).
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Methodological Choices
Qualitative: Focus Group
The use of focus groups is a qualitative, methodological approach designed to
help researchers understand how people view and gain meaning from a specific subject
matter. It is often used as an initial component of a research study (Doody, Slevin, &
Taggart, 2013). Participants are more likely to share opinions in a group when the
members of the group are similar (Doody et al., 2013). Doody and colleagues (2013)
found the group should consist of four to fourteen participants, so the group would not be
too large where participants felt intimidated to share opinions, yet large enough to
produce diversity of views. Both Friedman and colleagues (2012) and Carter and
colleagues (2010) reported using audio-recordings of the focus group discussions helped
researchers more accurately obtain information. Friedman and colleagues (2012) also
found using open-ended questions with one moderator and one note taker was the best
way to conduct a focus group. A focus group was utilized as the first piece of this study
to validate the understanding of the survey among the target population and gain some
very preliminary ideas about their opinions on prostate cancer.
Quantitative: Survey
Surveys have been conducted in the past to understand knowledge and attitudes
regarding prostate cancer and screening among men from various ethnicities. Shaw,
Vivian, Orzech, Torres, and Armin (2012) studied prostate cancer screening attitudes and
concluded relationships were highly influential on attitudes toward prostate cancer
screening in a qualitative and quantitative four-year prospective study. Shaw and
colleagues (2012) used mainly chart abstraction and self-reported surveys among White,
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African American, Vietnamese, and Latino patients (n = 297) from a community health
center serving low-income and underserved patients.
Allen and colleagues (2011) conducted surveys examining prostate cancer
knowledge; screening preferences, history, and decisions; decisional consistency; and
decision self-efficacy in 12 worksites among men (n = 812) who were 45 years old or
older and predominately (89%) White, non-Hispanic. It was reported men of other
ethnicities than White, non-Hispanic needed the most assistance with the informed
decision-making process for prostate cancer screening. A sample of 1,089 men from
various ethnicities, who were 40-74 years old, were surveyed using the Gesellschaft für
Konsumforschung Custom Research, Limited Liability Company's Knowledge Panel® to
assess if the men intended to follow the USPSTF’s recommendation not to participate in
a PSA test, or if they intended to participate in a PSA test (Squiers et al., 2013). Factors
that were positively correlated with having a PSA test done were higher income, having
had a PSA in the past two years, identifying as Black, and being somewhat to very
worried concerning risk for prostate cancer diagnosis. Telephone surveys were
distributed among non-Latino White, Latino, African American, and Asian men who
were first-degree relatives of men who were diagnosed with prostate cancer (Glenn et al.,
2012). The researchers found fewer than 50% of these 1,029 men had participated in a
PSA test throughout the past year. Factors that increased screening were having fewer
barriers, having a physician recommend screening, having previously completed a PSA
test, and having a first-degree relative as his brother versus his father (in all ethnic groups
besides African Americans).
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The use of surveys has also been implemented in studies involving African
American men. Patel and colleagues (2010) conducted surveys in three urban cities in
Meharry Community Networks Program in Tennessee among low-income African
American men (n = 293). The researchers concluded information regarding predictors of
and obstacles to screening should be included in educational interventions among African
American men. During a health fair, 229 African American men, who were 18 years old
or older, were surveyed (Mitchell, 2011). It was found that several ecological and social
factors influence health behavior. The survey consisted of a few questionnaires compiled
into a self-administered packet. Mitchell (2011) was successful in developing a survey
by combining several existing surveys for a specific population. Carter and colleagues
(2010) conducted pre-test and post-test surveys among African American men (n = 76) in
rural Alabama and found African American men were reluctant to discuss personal health
issues. An educational intervention increased screening participation by 48% and
increased knowledge of prostate cancer by 85% in one year.
Studies conducted among Afro-Caribbean American men have also utilized
surveys as a data collection method. A total of 143 Haitian American men were given
surveys to look at the congruence of perceived susceptibility with actual risk, the
relationship between fear and perceived susceptibility, and how fear and perceived
susceptibility correlate with screening behavior (Kleier, 2010). It was reported that
perceived susceptibility was lower than actual risk, and perceived susceptibility was
correlated with both fear and screening behavior, but fear was not correlated with
screening behavior. The Powe Fatalism Inventory and the Personal Integrative Model of
Prostate Cancer Disparity Survey were used to gather information from 211 United
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States-born and Caribbean-born Black men from 39-75 years old living in South Florida
(Cobran et al., 2013). Place of birth and level of prostate cancer fatalism did not
significantly influence PSA testing practice.
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CHAPTER III
METHODOLOGY
Setting and Sample
The setting for the study consisted of five churches in South Florida. The
churches were selected through a convenience sample due to common involvement in the
CHAMP organization. Based on the most recently published information on these
churches, the demographic breakdown on ethnicity, excluding women and children,
consisted of approximately 40% African American and approximately 60% AfroCaribbean American men (Parchment, 2004).
Preliminary data was obtained for this study from a focus group conducted at one
of the participating churches. The sample consisted of eight African American and AfroCaribbean American men. All five churches were the setting for the distribution of the
self-administered surveys. The surveys distributed included information on
demographics, personal and family health history, prostate cancer knowledge, decisional
conflict, perceived barriers, and spiritual well-being. Approximately 190 men from all
five churches attend church on a regular basis, according to church leaders’ estimates.
In this study, an African American man was defined as a man who identifies
himself racially as Black, lives in the United States of America, and is of African descent.
An Afro-Caribbean American man was defined as a man who identifies himself racially
as Black, lives in the United States of America, and is of African and Caribbean descent,
including, but not limited to Jamaican, Bahamian, Trinidadian, Haitian, and Guyanese.
The inclusion criteria were men who self-identified as (a) African American or
Afro-Caribbean American, even if they also self-identified as part of another ethnicity,
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(b) able to understand written and spoken English, (c) over 21 years old, (d) born a
genetic male and still having at least part of his prostate (even if he had prostate surgery),
and (e) willing to participate throughout the entire study. Exclusion criteria were men
who self-identified as (a) not even partially African American or Afro-Caribbean
American, (b) not able to understand written and spoken English, (c) under 21 years old,
(d) not born a genetic male and not having at least a portion of his prostate, and (e) not
able to participate throughout the entire study. Men had the option to refuse to participate
or remain part of the study at any time.
The sample size for the surveys was calculated a priori. Considering a standard
deviation of 1.6, as reported on a previous study that used the Prostate Cancer Screening
Education (PROCASE) Knowledge Index (Hevey et al., 2009), this study was powered
with a 95% confidence interval of an estimated one-point width. Given the mean of 7.5
(SD = 1.6) from Hevey and colleagues (2009), 40 participants were needed to estimate a
95% confidence interval with a one-point width. Therefore, 40 African American men
and 40 Afro-Caribbean American men were needed. Thus, if the observed mean was 7.5,
then the 95% confidence interval of one-point width would range from 7.0 to 8.0, which
would be fairly precise (Cohen, 1988).
The software GPower (version 3.1) was used post hoc to conduct power analyses.
First, a power analysis was done for a two-tail t-test with a mean difference between two
independent means (two groups). The effect size was large (0.8), and the alpha error
probability was 0.05 for a power of 0.95. Second, a power analysis was done for a chisquare test with a cross table analysis with a large effect size (0.5), and an alpha error
probability of 0.05 for a power of 0.95.
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Procedures
This study was a mixed methods study with a non-experimental design. The
qualitative component consisted of conducting a focus group. The quantitative portion of
the study entailed the completion of a survey packet (see Appendix A). Approval was
obtained from the Florida International University Institutional Review Board (IRB) to
undergo the proposed research study before recruitment or any data collection was
conducted (see Appendix B).
The church leaders and Principal Investigator (PI) were able to recruit participants
via word of mouth, verbal announcements, church bulletins, and posted flyers. Word of
mouth was a recruitment strategy that was also successful in another study involving
prostate cancer in African American men (Friedman et al., 2009). No prescreening
occurred, but convenience sampling of men who were attending one of the churches was
used to choose the study sample.
With both the focus group and the surveys, the PI verbally explained to the
potential participants during or after each church meeting the purpose of the study, what
would be asked of the participants during the study, the timeframe of the study, the risks
and benefits of participation, and the voluntary nature of participation, along with ability
to terminate without repercussions at any time. This information was also printed on the
consent forms. Two copies of the consent forms were handed out to each participant.
Participants read the consent forms; any questions were answered to their satisfaction;
and they signed both copies prior to the start of the focus group or survey questionnaires.
One copy was given to the participant, and the other copy was retained by the PI. After
the participant signed the informed consent, the questionnaire packet was distributed.
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Upon completion of the survey packets, the participants returned the packets to the PI,
who encouraged completeness of each packet and thanked each man for participating.
Data Collection
Focus Group
After the consent process and survey packets were completed, the focus group
discussion commenced, which lasted approximately 45 minutes. Although the purpose of
the focus group was to validate understanding of the survey questions, four other prostate
health topics were also discussed: health communication, knowledge, informed decision
making, and barriers and beliefs. The PI, as the moderator, introduced each topic, and an
assistant moderator managed the tape recorder and took written notes. All men who
participated in the focus group were encouraged to share feelings and opinions freely.
Following the focus group, the participants were provided with a free meal. The audio
recording was transcribed verbatim into Microsoft Word®.
Surveys
Participants for the surveys were recruited by church leaders and the PI via word
of mouth, verbal announcements, church bulletins, and posted flyers at least one week
prior to survey distribution. A verbal announcement was again made at the time of the
survey distribution in each church meeting or service. Informed consent was signed
before the surveys were delivered. The self-administered surveys were then distributed at
all five churches. The surveys included six components: (1) demographic questions, (2)
personal and family health history questions, (3) prostate knowledge questions, (4)
informed decision-making questions as measured by men’s level of conflict in the
decision regarding prostate screening, (5) barriers to screening questions, and (6) beliefs
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regarding spiritual well-being questions. The PI collected all completed surveys during
that same church meeting or service. No surveys were mailed to the PI or collected at a
later date.
Instruments
Several instruments were combined into one questionnaire packet. Knowledge
was assessed using a combined version of the Knowledge and Practice of Prostate Health
Questionnaire and PROCASE Knowledge Index. Self-efficacy measured as conflict was
reported from the Low Literacy Decisional Conflict Scale. Barriers were identified from
a version of the Perceived Barriers Survey. Spiritual well-being was evaluated using the
Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being, a modified
version for non-illness (FACIT-Sp Non-Illness).
General prostate health knowledge was measured by two questions from a
modified version of the Knowledge and Practice of Prostate Health Questionnaire. It was
important to examine men’s understanding of the prostate before trying to examine their
understanding of prostate cancer (Adesanya, Shittu, Awobajo, Otulana, & Adesanya,
2013). Adesanya and colleagues (2013) tested internal consistency and reliability of the
Knowledge and Practice of Prostate Health Questionnaire during a pilot study among ten
participants from Nigeria. A test-retest method was used, with two weeks between
testing sessions. Internal consistency and reliability of the instrument was evident with
the Pearson correlation reported as 0.85 (Adesanya et al., 2013).
Prostate cancer knowledge was also measured by a 10-item knowledge index
called the PROCASE Knowledge Index (Radosevich et al., 2004). In order to establish
internal consistency reliability and validity, Radosevich and colleagues (2004) collected
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data via telephone interviews from a sample of 875 male veterans aged 50 and older, who
were mainly White. The internal consistency reliability for the PROCASE Knowledge
Index was found to be fair by Radosevich and colleagues (2004), with a Kuder–
Richardson 20 (KR-20) value of 0.68. The validity of the PROCASE Knowledge Index
was determined in three ways: content, construct, and criterion. The content was
determined to be valid by the team of researchers during the developmental phase of the
study. Construct validity was tested for convergent and discriminate validity. The
convergent validity test indicated high PROCASE Knowledge Index scores were
significantly associated with a history of exposure to PSA information, a history of
abnormal PSA levels, and higher formal education. For discriminate validity, medication
use and comorbidities demonstrated no statistically significant differences between low
and high PROCASE Knowledge Index scores, except for chronic obstructive pulmonary
disease. Criterion validity compared the results of the test with 29 expert health
professionals from the Veterans Affairs (VA) Medical Center in Minneapolis who were
from either urology or internal medicine services. These health professionals
(physicians, registered nurses, and advanced practice nurses) completed a written version
of the knowledge questions for comparison. A high percent agreement was found
between the expert health professionals and all items of the PROCASE Knowledge Index
questions with D-values all greater than 0.20 (Radosevich et al., 2004). The two scales
combined to form this study’s Prostate Knowledge Scale, which consisted of 12 true or
false questions. Four questions formed the symptoms subscale, and three questions were
combined to produce the screening subscale. High knowledge for the total score and two
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subscale scores yielded a score greater than 70%, and a low score was 70% or less
(Adesanya et al., 2013; Radosevich et al., 2004).
Self-efficacy was measured by the level of decisional conflict concerning making
an informed decision regarding prostate screening, as reported in the Low Literacy
Decisional Conflict Scale. Self-efficacy is the level of confidence to which one feels a
decision can be made and followed through, and it affects health behavior (Rosenstock et
al., 1988). Low self-efficacy is also a factor for increasing decisional conflict (Allen et
al., 2011). The Decisional Conflict Scale was chosen to measure self-efficacy because
conflict and self-efficacy were found to affect each other in the informed decisionmaking process for prostate cancer screening by Allen and colleagues (2011). In
addition, Lee and colleagues (2012) used the HBM to guide their study and reported on
the relationship of self-efficacy’s impact on screening behavior. The researchers found
low self-efficacy was correlated with low participation in PSA testing among both
African American and Afro-Caribbean American participants. The framework of the
HBM was also used by Holt and colleagues (2009) to connect self-efficacy and decision
making regarding prostate screening, and they concluded self-efficacy for screening was
an essential part of making an informed decision to participate in prostate screenings.
The Low Literacy Decisional Conflict Scale was developed by Linder and
colleagues (2011), with a total score and four subscale scores: uncertainty, informed,
values, and support. The total score and all subscale scores from the Decisional Conflict
Scale range from 0-100, with the higher the total score, the higher the level of decisional
conflict (Linder et al., 2011). The items on the Decisional Conflict Scale have been
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interpreted as a score less than 25 is low conflict, 25-37.5 is moderate conflict, and
greater than 37.5 is high conflict (O’Connor, 1995).
The Decisional Conflict Scale measured conflict in this study regarding prostate
screening from the question, “Which do you prefer? Getting a PSA test, not getting a
PSA test, or unsure.” The low literacy version was revised from the original 16-item
Decisional Conflict Scale (O’Connor, 1995). The Decisional Conflict Scale was
developed by O’Connor (1995) to assess to what degree a person feels informed, how
uncertain someone is in his/her decision, and how much he/she perceives his/her decision
is in keeping with his/her values. The Decisional Conflict Scale was tested among 909
participants regarding the decision concerning breast cancer screening or influenza
immunization.
The Low Literacy Decisional Conflict Scale was used because it was designed to
be simple for participants to understand and complete (Linder et al., 2011). Linder and
colleagues (2011) conducted a randomized, controlled trial among 149 men from Texas
with a mean age of 54. These men were Black (73.6%), White (16.2%), MexicanAmerican, Hispanic/Latino (8.8%), and Other (1.4%). The researchers reported a high
discriminate validity regarding participation in prostate cancer screening using the Low
Literacy Decisional Conflict Scale. The Low Literacy Decisional Conflict Scale had a
fair construct validity except for the supported subscale, with most r's > 0.40, and an
excellent internal consistency and reliability (alphas > 0.80). Taylor and colleagues
(2006) reported a fairly good alpha reliability of 0.76 after two items were eliminated for
the Decisional Conflict Scale among a sample of 238 African American men aged 40-70
from Washington, DC. These two items were confusing for the participants and were

48

eliminated. The scale used in this study was comprised of 10 questions with a response
format of “yes,” “no,” and “unsure.”
Barriers were identified using a modified version of the Perceived Barriers Survey
from the Cancer Awareness Survey called the Perceived Barriers Survey (Parchment,
2004). Eleven barriers were ranked from the greatest (being one) to the least (being
eleven). Beliefs were examined in terms of spiritual well-being. Spiritual well-being
was measured using the FACIT-Sp Non-Illness, which can be applicable to all men
because it does not include a specific illness (Visser, Garssen, & Vingerhoets, 2010).
The survey has the last two questions modified to assess for beliefs related to difficult
times, as opposed to chronic illness or prostate cancer. The questionnaire has 12
questions comprising three subscales: meaning, peace, and faith. Visser and colleagues
(2010) found a relationship between high levels of spirituality and high levels of wellbeing in most studies and particularly in all 16 studies that used the FACIT-Sp version
questionnaire. The original validation study for the FACIT-Sp was conducted among
1,617 participants, with 83.1% being participants with cancer (Peterman, Fitchett, Brady,
Hernandez, & Cella, 2002). The median age was 54.6, a total of 53% were female, and
47% were male. Internal consistency and reliability were high even among different
cultures (Hispanic compared to White non-Hispanic compared to Black non-Hispanic).
The Cronbach's alpha for the total scale was 0.87, for the meaning/peace subscale was
0.81, and for the faith subscale was 0.88 (Peterman et al., 2002). Spirituality does not
always consist of religion but does include seeking purpose and meaning in life (Holt et
al., 2009). Visser and colleagues (2010) agreed meaning, peace, and faith were all
components of spirituality.
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Data Management and Analysis
The data were managed using two systems called the Research Electronic Data
Capture (REDCap) and the Statistical Package for the Social Sciences (SPSS). Twice the
data were coded in REDCap, including assigning missing codes where questions were
not answered. These codes were compared and adjustments were made as necessary.
The data were entered separately and compared. The raw data were used to solve any
differences between the two entries. The data were then exported into SPSS.
Consistent coding principles were used in managing the data to ensure accurate
recording of the data. Data integrity was maintained throughout the various steps of the
study: at collection, coding, and entry. Each participant was assigned a number as an
identifier. Most questionnaires were completed. Although participants were encouraged
to complete each question, some questions remained unanswered. The PI collected,
managed, analyzed, and interpreted the data.
Descriptive statistics were computed, including frequency, mean, and standard
deviation, for all independent and dependent variables separately. Independent variables
included questions from the Demographic Questionnaire and the Personal and Family
Health History Questionnaire. Demographic characteristics were assessed for each
outcome to determine homogeneity in characteristics across outcome variables.
Dependent variables included questions from the following questionnaires: the Prostate
Knowledge Scale, the Decisional Conflict Scale, the Perceived Barriers Survey, and the
FACIT-Sp Non-Illness scale (see Table C1 in Appendix C).
T-tests were used for the analysis of age, the Prostate Knowledge Scale, the
Decisional Conflict Scale, and the FACIT-Sp Non-Illness scale for beliefs. Chi-square
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tests were used for the analysis of the demographics, except for age and for the Personal
and Family Health History Questionnaire. A Mann-Whitney U Test was used for the
Perceived Barriers Survey. Significance was measured at p < 0.05. Links were made
among the theory of the HBM, research, and implications for practice.
Research Question 1: “Is there a relationship between ethnicity (African
American and Afro-Caribbean American men) and level of prostate health knowledge?”
Two questionnaires were examined to answer the first research question. The first
questionnaire consisted of two questions from a modified version of the Knowledge and
Practice of Prostate Health Questionnaire (Adesanya et al., 2013). The two questions
investigated knowledge of prostate gland function and location, and had a score range
from 0-2 in a true or false format, with the correct response receiving one point and the
incorrect response receiving no points for each question. A higher score indicated a
higher level of general prostate knowledge.
The second set of questions was taken from the PROCASE Knowledge Index,
with 10 questions and a score range of 0-10, in a true or false format. A higher score
indicated a higher level of prostate cancer and PSA knowledge. Both scores were
analyzed together for a total score of 0-12. Two subscale scores, which only included
seven of the total 12 questions, also were analyzed. The remaining five questions of the
12 were not part of a subscale score and were only analyzed as part of the total
knowledge score. The knowledge of a screening subscale score was calculated using
questions six, seven, and eight of the Prostate Knowledge Scale for a total score of 0-3.
The knowledge of symptoms subscale score was calculated using questions three, four,
nine, and ten of the Prostate Knowledge Scale for a total score of 0-4. For the total and
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two subscale scores, the higher the number of the score, the higher the prostate
knowledge.
Research Question 2: “Is there a relationship between ethnicity (African
American and Afro-Caribbean American men) and self-efficacy (measured by men’s
level of conflict in making an informed decision regarding prostate screening)?” The
second research question was answered by the use of the Low Literacy Decisional
Conflict Scale. The scale contained 10 items in three response categories, with the
format of the questions being yes (for a score value of 0), unsure (for a score value of 2),
or no (for a score value of 4). The total score for the scale is determined by summing all
values for each of the 10 questions, dividing by 10, and multiplying by 25. The score
ranges from 0 (no decisional conflict) to 100 (extremely high decisional conflict). The
four subcategories are uncertainty subscale score, which consists of two items (items 9
and 10) that are summed, divided by two, and multiplied by 25 for a score range from 0
(feels extremely certain of best choice) to 100 (feels extremely uncertain of best choice);
informed subscale score, which consists of three items (items 1, 2 and 3) that are
summed, divided by three, and multiplied by 25 for a score range from 0 (feels extremely
informed) to 100 (feels extremely uninformed); values clarity subscale score, which
consists of two items (items 4 and 5) that are summed, divided by two, and multiplied by
25 for a score range from 0 (feels extremely clear of personal values for benefits and
risks/side effects) to 100 (feels extremely unclear of personal values); and support
subscale score, which consists of three items (items 6, 7, and 8) that are summed, divided
by three, and multiplied by 25 for a score range from 0 (feels extremely supported in
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decision making) to 100 (feels extremely unsupported in decision making) (O’Connor,
1995).
Research Question 3: “Is there a relationship between ethnicity (African
American and Afro-Caribbean American men) and influencing factors on prostate
screening behavior, including barriers to screening and beliefs measured by spiritual
well-being?” Two scales were utilized to answer the third research question. One scale,
the Perceived Barriers Survey, measured the level of perceived barriers regarding
participation in a prostate screening by ranking each barrier. The Perceived Barriers
Survey is a modified version of the Perceived Barriers Survey from the Cancer
Awareness Survey, with the greatest barrier being number one, to the least barrier being
number eleven. The score of each of the 11 barriers was averaged for African American
and Afro-Caribbean American men. Then, it was determined which barrier was the
greatest and which was the least.
The second scale was regarding spiritual well-being, which is called the FACITSp Non-Illness. The questionnaire has 12 questions containing three subscales: meaning
(items 2, 3, 5, 8), peace (items 1, 4, 6, 7), and faith (items 9, 10, 11, 12), each with a score
range of 0-16. The questionnaire uses a 5-point Likert-type scale, with each response
having a point value assigned as either not at all (0), a little bit (1), somewhat (2), quite a
bit (3), and very much (4) (Visser et al., 2010). After items 4 and 8 were reverse-coded,
each subscale score was summed, multiplied by four, and then divided by the number of
items answered. A total spirituality score was then derived by adding each of the three
subscale scores to have a total score range of 0-48. The direction of this scale is the
higher the score, the higher the level of spiritual well-being.

53

Human Participants
Risks to Human Participants
The participants were involved in a focus group or surveys. The age range was
any age over 21. Health status was not an inclusion or exclusion factor for this study.
Special vulnerable populations, such as fetuses, neonates, pregnant women, children,
prisoners, institutionalized individuals, or others who may be considered vulnerable
populations, did not participate in this study.
No potential physical, financial, or legal risks to participants were apparent. The
settings were churches that men regularly attended in order to provide men with a
comfortable, familiar, and convenient environment for the study. Minimal risk was from
time lost to participate in the focus group and survey questionnaires. The men
participated during regularly scheduled church meetings and services, the survey packet
was brief, and the questionnaire process was conducted privately to decrease participants’
burden during the study.
Also, potential risks were emotional and psychological discomfort and risk related
to the sensitive nature of asking questions on prostate health, especially questions
regarding sexual function or dysfunction. This risk was minimal, and the PI was
available to answer questions and resolve any concerns regarding the study and its
questions. The risks to participants were reasonable in relation to the importance of the
knowledge and benefits gained. No issues arose with the participants during the study.
Potential Benefits to Human Participants and Others
The most prominent potential benefit of the research was increased knowledge
and understanding of African American and Afro-Caribbean American men’s level of
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prostate health knowledge, level of conflict in the decision regarding prostate screening,
and influencing factors on prostate screening behavior, including barriers to screenings
and spiritual well-being. Another benefit was raising awareness in the African American
and Afro-Caribbean American men who participated in the study, as evidenced by the
focus group feedback. No physical or financial direct benefits were provided to
participants in this study.
Adequacy of Protection against Risks
The signed informed consent documents were stored in a locked cabinet to protect
against risks for this study. In addition, participants took part in the focus group
anonymously or the surveys privately. Care was taken to have the PI available to answer
any questions in a sensitive manner. Data were stored in a locked cabinet, and names of
the participants were not available to anyone but the PI. Access to individually
identifiable private information, including names of participants, was only available to
the PI. The data were entered into REDCap and SPSS with identification numbers, not
individual private identifiers. A password-protected computer was used for data entry.
The PI established a monitoring plan for the overall framework of data and safety
monitoring. The PI also was responsible for monitoring and reporting adverse events to
the IRB, but none occurred. These actions were very effective protective measures and
helped prevent and minimize potential risks, including risks to the privacy of individuals
or confidentiality of data.
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CHAPTER IV
RESULTS
Sample of Focus Group Participants
The focus group consisted of men (n = 8) aged 40-70 years old. The average age
was 53.8 years old (SD = 10.3). For race, all self-identified as Black. For ethnicity, six
self-identified as Afro-Caribbean American, one as African American, and one as “other”
(not specified). All were married. For education, two reported having less than a high
school education or General Educational Development (GED) completion, three had a
high school education/GED completion, one had a bachelor’s degree, and two had a postbaccalaureate education. Household annual income or salary was reported as one
$20,000 to less than $40,000, one $40,000 to less than $60,000, three $60,000 to less than
$80,000, two greater than $80,000, and one did not respond. For health insurance
coverage, five had private insurance, two had public, and one did not respond. For
religious affiliation, two marked Protestant, four marked “other” (one Christian, one New
Testament, one Pentecostal, and one only marked “other”), one had a double answer of
Muslim and Mormon/LDS, and one did not mark anything.
Focus Group Questionnaire Packet
The focus group members were instructed to review the survey questions from the
survey packet. Specifically, the wording used for the questionnaire packet was examined
for validity of understanding and cultural relevance because various cultures have used
different words to describe health issues, and words could have diverse meanings (Sobo,
2009). Every participant agreed all directions were clear and all questions helped raise
awareness of prostate health. No suggestions were made to change anything in the
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packet before the surveys were to be conducted. Based on the participants’ feedback
from the focus group, the conclusion was the survey packet appeared to be clear and
adequate. When asked concerning each questionnaire, the participants reiterated that the
survey packet should be administered as it was presented to them. None thought any
alterations, additions, or deletions were necessary. In fact, one gentleman said, “I
actually liked, let me see, what is it? The Decisional Conflict Scale. I think that page
really is an eye-opening page... I was going through it and was like whoa! The benefits,
what options are available to you. Wow, I don’t know a lot of stuff. It was good
awareness.” Therefore, because no recommendations were made to change the questions
and all directions were clear, the questionnaire packet was administered without any
alterations for the main quantitative survey portion of the study.
Sample of Survey Participants
A total sample of 113 men completed the surveys (n = 113). The characteristics
of age, marital status, education, annual income, health insurance coverage, and religion
for the survey sample are presented in Table 1. The participants’ age range in the surveys
was 23-93 years old with a mean age of 59.5 years old (SD = 16.4). Participants
typically self-identified as Black (n = 92, 81.4%), were either African American (n = 49,
45.4%) or Afro-Caribbean American (n = 38, 35.2%), were married (n = 81, 75.7%), had
an associate’s degree or some college or trade school (n = 36, 34.3%), made $40,000 to
less than $60,000 annually (n = 28, 29.8%), had private insurance (n = 59, 56.7%), and
(n = 41, 36.3%) marked “other” as religion. For religion, “other” was selected as Baptist
(n = 15, 13.3%), Christian/Christ/Jesus Christ/Christianity (n = 12, 10.6%), Pentecostal
(n = 4, 3.5%), Church of God (n = 3, 2.7%), Episcopalian (n = 3, 2.7%), Anglican
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(n = 2, 1.8%), and not specified (n = 2, 1.8%). For race, “other” was selected as
Latin/Black (n = 1, 0.9%), Mixed (n = 1, 0.9%), W.I. Black (n = 1, 0.9%), and not
specified (n = 1, 0.9%). For ethnicity, “other” was selected as not specified (n = 11,
9.7%), American (n = 2, 1.8%), African (n = 1, 0.9%), Irish/German/American (n = 1,
0.9%), Jamaican (n = 1, 0.9%), and Latin/Black (n = 1, 0.9%).
The remaining results and discussion will be limited to African American and
Afro-Caribbean American participants’ responses, since this is the focus of this study.
The characteristics of age, marital status, education, annual income, health insurance
coverage, and religion for African American and Afro-Caribbean American participants
are presented in Table 1. African American participants (n = 49) had a mean age of 53.4
(SD = 16.1). African American participants typically were married (n = 29, 60.4%), had
an associate’s degree or some college or trade school (n = 16, 34.0%), made $40,000 to
less than $60,000 annually (n = 13, 31.7%), had private insurance (n = 28, 59.6%), and
indicated “other” for religion (n = 27, 58.7%). For religion, “other” for African
American participants was selected as Baptist (n = 15, 30.6%),
Christian/Christ/Christianity (n = 8, 16.3%), not specified (n = 2, 4.1%), Episcopalian
(n = 1, 2.0%), and Pentecostal (n = 1, 2.0%).
Afro-Caribbean American participants (n = 38) had a mean age of 61.2
(SD = 16.2). Afro-Caribbean American participants typically were married (n = 32,
84.2%), had an associate’s degree or some college or trade school (n = 12, 31.6%), made
$40,000 to less than $60,000 annually (n = 9, 25.7%), had private insurance (n = 25,
67.6%), and indicated Catholic for religion (n = 17, 44.7%). For religion, “other” for
Afro-Caribbean American participants was selected as Pentecostal (n = 3, 7.9%),
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Anglican (n = 2, 5.3%), Christian/Jesus Christ (n = 2, 5.3%), Church of God (n = 2,
5.3%), and Episcopalian (n = 1, 2.6%). Differences in age (t = -2.215, p = 0.030) and
religion (χ2 = 14.082, p = 0.001) were observed to be statistically significant between
African American and Afro-Caribbean American participants.

Table 1
Characteristics of Participants
Characteristics
Total Sample
(n = 113)
Mean Age (SD)a
Raceb
Black
Caucasian
Latino
Asian/Pacific
Islander
Other
Ethnicityb
African American
Afro-Caribbean
American
Hispanic
Other
Marital Statusc
Married
Single
Divorced
Partnered
Widower
Educationc
Less than high school
/GED
High school/GED
Associate’s degree or
some college or trade
school
Bachelor's degree
Post-baccalaureate

African
American Men
(n = 49)

59.5 (16.4)
%
81.4%
4.4%
2.7%
2.7%

53.4 (16.1)
%
100.0%
0.0%
0.0%
0.0%

AfroStatistics
Caribbean
American
Men (n = 38)
61.2 (16.2)
t = -2.21*
%
100.0%
0.0%
0.0%
0.0%

3.5%
%
43.4%
33.6%

0.0%
%
100.0%
0.0%

0.0%
%
0.0%
100.0%

3.5%
15.0%
%
71.7%
15.0%
5.3%
1.8%
0.9%
%
1.8%

0.0%
0.0%
%
59.2%
26.5%
8.2%
4.1%
0.0%
%
0.0%

0.0%
0.0%
%
84.2%
10.5%
5.3%
0.0%
0.0%
%
5.3%

21.2%
31.9%

20.4%
32.7%

28.9%
31.6%

18.6%
9.5%

18.4%
24.5%

23.7%
10.5%
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χ2 = 6.50

χ2 = 5.73

education
Incomea
Less than $20,000
$20,000 to less than
$40,000
$40,000 to less than
$60,000
$60,000 to less than
$80,000
Greater than $80,000
Health Insurancea
Private
Public
None
Private and Public
Religionc

%
9.7%
13.3%

%
8.2%
10.2%

%
14.3%
20.0%

24.8%

26.5%

25.7%

15.9%

16.3%

20.0%

19.5%
%
52.2%
27.4%
8.0%
4.4%
%

22.4%
%
57.1%
26.5%
8.2%
4.1%
%

20.0%
%
67.6%
24.3%
5.4%
2.7%
%

χ2 = 1.66

χ2 = 0.71

χ2 =
14.08*

Other
36.3%
55.1%
26.3%
Catholic
31.0%
10.2%
44.7%
Protestant
25.7%
28.6%
28.9%
Note. n’s ranged from 94-108 for the Total Sample, 47-48 for African American men
and 36-38 for Afro-Caribbean American men due to missing data.
a
not all participants from all ethnicities answered the question. bnot all participants from
the Total Sample answered the question. cnot all African American and Total Sample
participants answered the question.
*p < 0.05.

The Personal and Family Health History Questionnaire’s results are displayed in
Table 2. Several African American participants (n = 22, 45.8%) and Afro-Caribbean
American participants (n = 14, 37.8%) reported having a family history of prostate
cancer or not knowing if they have a family history of prostate cancer. Also, some
African American participants (n = 12, 25.5%) and Afro-Caribbean American
participants (n = 6, 16.7%) reported not having a doctor check the prostate, or not
knowing if a doctor had checked the prostate. In addition, almost half of African
American participants (n = 23, 47.9%) and nearly a third of Afro-Caribbean American
participants (n = 11, 29%) did not have a PSA blood test done, or did not know if one
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was conducted. Furthermore, approximately one-third of African American participants
(n = 16, 33.3%) and Afro-Caribbean American participants (n = 11, 28.9%) reported
having had urinary problems of difficulty urinating, pain on urination, frequent urination,
blood in the urine, or not knowing if they experienced such urinary problems. No
statistically significant differences were observed in the personal and family history
questionnaire responses between African American and Afro-Caribbean American
participants.
Table 2
Personal and Family Health History Questionnaire
Questions/Responses
African
Afro-Caribbean
Statistics
American
American
Men (n = 49) Men (n = 38)
1. History of prostate cancer in
χ2 = 4.16
a
your family
Yes
25%
32.4%
No
54.2%
62.2%
I don’t know
20.8%
5.4%
χ2 = 2.86
2. Doctor ever checked your
prostatea
Yes
74.5%
83.3%
No
25.5%
13.9%
I don’t know
0%
2.8%
b
3. Ever had a PSA
χ2 = 3.59
Yes
52.1%
71.1%
No
39.6%
21.1%
I don’t know
8.3%
7.9%
b
4. Ever had urinary problems
χ2 = 1.26
Yes
25%
26.3%
No
66.7%
71.1%
I don’t know
8.3%
2.6%
Note. n’s ranged from 47-48 for African American men and 36-38 for Afro-Caribbean
American men due to missing data.
a
not all participants from both ethnicities answered the question. bnot all African
American participants answered the question.
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Prostate Knowledge
The Prostate Knowledge Scale had a total knowledge score with subscale scores
in knowledge of screening and knowledge of symptoms. These results are reported in
Table 3. The total knowledge score had a range from 0-12, the knowledge of screening
subscale score had a range from 0-4, and the knowledge of symptoms subscale score had
a range from 0-3. The higher the score, the higher the level of prostate knowledge for the
total score and both subscale scores. High knowledge was determined to be a score
greater than 70%, and a low score was 70% or less for the total, as well as the subscale
scores (Adesanya et al., 2013; Radosevich et al., 2004).
Both African American participants (n = 49, 8.3) and Afro-Caribbean American
participants (n = 29, 8.2) had a low total score. Also, both African American participants
(n = 46, 2.7) and Afro-Caribbean American participants (n = 34, 2.8) had a low
knowledge of symptoms subscale score. However, African American participants
(n = 47, 2.4) and Afro-Caribbean American participants (n = 35, 2.3) had a high
knowledge of screening subscale score.
The symptom subscale score contained both the lowest correctly answered and
highest correctly answered item. Only 33.3% (n = 16) of African American participants
and 27.0% (n = 10) of Afro-Caribbean American participants answered item 3 (“Prostate
cancer is the most common cause of problems with urination.”) correctly, which was the
lowest score out of any question. The question both African American participants
(n = 45, 93.8%) and Afro-Caribbean American participants (n = 34, 91.7%) answered
correctly the most was item 4 (“Prostate cancer never causes problems with urination.”).
The differences observed were not statistically significant for the total knowledge scale
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score (t = 0.221, p = 0.826), symptoms subscale score (t = -0.595, p = 0.554), or
screening subscale score (t = 1.155, p = 0.252) between African American and AfroCaribbean American participants.
Table 3
Prostate Knowledge Scale
Scale/Subscales
African
Afro-Caribbean
Statistics
American Men American Men
M (SD)
M (SD)
(n = 49)
(n = 38)
a
Total
8.3 (1.4)
8.2 (2.0)
t = 0.22
(items 1-12)
Symptomsa
2.7 (0.8)
2.8 (0.9)
t = -0.60
(items 3, 4, 9, 10)
Screeninga
2.4 (0.6)
2.3 (0.5)
t = 1.16
(items 6, 7, 8)
Note. The total score ranges from 0-12. The symptoms subscale score ranges from 04. The screening subscale score ranges from 0-3. A higher score means a higher level
of prostate knowledge for the total score and both subscale scores. n’s ranged from 4147 for African American men and 29-35 for Afro-Caribbean American men due to
missing data.
a
not all participants from both ethnicities answered the question.

Decisional Conflict
Self-efficacy was measured by men’s level of conflict in making an informed
decision regarding prostate screening using the Decisional Conflict Scale. The
Decisional Conflict Scale has a total score and four subscale scores: uncertainty,
informed, values, and support. These scores are depicted in Table 4. The Decisional
Conflict Scale examined the conflict from the question, “Which do you prefer? Getting a
PSA test, not getting a PSA test, or unsure.” Seven African American participants
(14.9%) and eight Afro-Caribbean American participants (22.2%) preferred not getting a
PSA test or unsure. The total score and all subscale scores from the Decisional Conflict
Scale ranged from 0-100. The higher the total score, the higher the level of decisional
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conflict (Linder et al., 2011). Both African American participants (n = 45, 36.0) and
Afro-Caribbean American participants (n = 31, 28.2) had moderate total decisional
conflict (O’Connor, 1995). The higher the uncertainty subscale score, the higher the
uncertainty of the choice. African American participants (n = 47, 36.2) and AfroCaribbean American participants (n = 37, 29.1) had moderate uncertainty regarding best
choice. The higher the informed subscale score, the greater the participant feels
uninformed. African American participants (n = 47, 41.1) felt highly uninformed and
Afro-Caribbean American participants (n = 36, 32.9) felt moderately uninformed of the
best choice. The higher the values subscale score, the greater the participant feels unclear
of personal values. African American participants (n = 47, 46.3) felt highly unclear and
Afro-Caribbean American participants (n = 36, 31.9) felt moderately unclear concerning
personal values for benefits and risks/side effects of the best choice. The higher the
support subscale score, the greater the participant feels unsupported in decision making.
African American participants (n = 45, 23.3) and Afro-Caribbean American participants
(n = 33, 23.2) felt highly supported in the decision-making process. The differences
observed for total (t = 1.178, p = 0.243), uncertainty (t = 0.882, p = 0.380), informed
(t = 1.070, p = 0.288), values (t = 1.659, p = 0.101), and support (t = 0.017, p = 0.987)
scores were not statistically significant between African American and Afro-Caribbean
American participants.
Table 4
Decisional Conflict Scale
Scale/Subscales
African
American Men
M (SD)
(n = 49)
Totala
36.0 (29.6)

Afro-Caribbean
American Men
M (SD)
(n = 38)
28.2 (26.2)
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Statistics

t = 1.18

(items 1-10)
Uncertaintya
36.2 (36.4)
29.1 (37.0)
t = 0.88
(items 9, 10)
Informeda
41.1 (37.2)
32.9 (31.5)
t = 1.07
(items 1, 2, 3)
Valuesa
46.3 (41.4)
31.9 (35.7)
t = 1.66
(items 4, 5)
Supporta
23.3 (24.2)
23.2 (28.2)
t = 0.02
(items 6, 7, 8)
Note. All scores range from 0-100. The higher the total score, the higher the level of
decisional conflict. The higher the uncertainty subscale score, the higher the
uncertainty of the choice. The higher the informed subscale score, the greater the
participant feels uninformed. The higher the values subscale score, the greater the
participant feels unclear of personal values. The higher the support subscale score, the
greater the participant feels unsupported in decision making. n’s ranged from 45-47 for
African American men and 31-37 for Afro-Caribbean American men due to missing
data.
a
not all participants from both ethnicities answered the question.

Barriers
The Perceived Barriers Survey, a modified version of the Perceived Barriers
Survey from the Cancer Awareness Survey, ranked barriers from the greatest barrier
being number one to the least barrier being number eleven. The results are presented in
Table 5. The greatest barrier (ranked as a 1 or 2) for African American participants was
“Can’t afford it” and “Doctor did not tell me I needed it,” with a count of 12 (24.5%).
The greatest barrier (ranked as a 1 or 2) for Afro-Caribbean American participants was
“Exam is embarrassing," with a count of 9 (23.7%). The differences in barriers observed
were not statistically significant between African American and Afro-Caribbean
American participants using A Mann-Whitney U Test.
Table 5
Barriers Ranked as One or Two for Prostate Cancer Screening
African American Men (n = 49)

Afro-Caribbean American Men
(n = 38)
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Top Ranked Barriers
1 Can’t afford ita

Doctor did not tell me
I needed ita
2 Dislike or fear of
doctorsa
3 No insurancea

Count
(%)
12
(24.5%)

Statistics
U = 443.0
p = 0.934

9
(18.4%)
7
(14.3%)

U = 424.5
p = 0.525
U = 461.5
p = 0.925
U = 392.5
p = 0.478

4 Exam is embarrassinga 6
(12.2%)

U = 337.5
p = 0.078

Did not think it was
importanta
Exam is
uncomfortablea
5 Fear of finding
cancera

Top Ranked Barriers
1 Exam is
embarrassinga

2 Exam is
uncomfortablea
3 No insurancea
Past problems with
doctorsa
4 No transportationa

Count
(%)
9
(23.7%)

8
(21.1%)
6
(15.8%)
5
(13.2%)

U = 445.5
p = 0.876

5
(10.2%)

U = 379.0
p = 0.327
U = 456.0
p = 0.659

5 Dislike or fear of
4
doctorsa
(10.5%)
a
Can’t afford it
No transportationa
U = 377.0
No insurancea
p = 0.337
Did not think it was
Past problems with
importanta
U = 383.0
doctorsa
Personal or religious
p = 0.272
beliefsa
6 Personal or religious
4 (8.2%) U = 343.0 6 Doctor did not tell me 3 (7.9%)
beliefsa
p = 0.173
I needed ita
Note. Participants ranked 11 possible perceived barriers to prostate cancer screening,
from greatest barrier (1) to least (11). Only barriers ranked the highest (i.e., 1 or 2)
were included in the table. n’s ranged from 37-39 for African American men and 2325 for Afro-Caribbean American men due to missing data.
a
not all participants from both ethnicities answered the question.

Beliefs
The FACIT-Sp Non-Illness scale to measure spiritual well-being had 12 questions
comprised of three subscales: meaning, peace, and faith. The results are displayed in
Table 6. Each subscale had a score range of 0-16. When combined a total spirituality
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score with a range of 0-48 was obtained. The higher the score, the higher the reported
level of spiritual well-being (Visser et al., 2010). Both African American participants
(n = 41, 42.6) and Afro-Caribbean American participants (n = 36, 41.9) had high total
spiritual well-being. Also, African American participants (n = 44, 14.6) and AfroCaribbean American participants (n = 37, 14.2) had high levels of meaning in life. In
addition, African American participants (n = 45, 13.3) and Afro-Caribbean American
participants (n = 38, 13.0) had high levels of peace in life. Furthermore, African
American participants (n = 41, 14.7) and Afro-Caribbean American participants (n = 37,
14.5) had high levels of faith in life. The differences observed for total (t = 0.442,
p = 0.660), meaning (t = 0.758, p = 0.451), peace (t = 0.481, p = 0.632), and faith
(t = 0.449, p = 0.654) scores were not statistically significant between African American
and Afro-Caribbean American participants.
Table 6
FACIT-Sp Non-Illness Scale
Scale/Subscales
African American
Afro-Caribbean
Statistics
Men
American Men
M (SD)
M (SD)
(n = 49)
(n = 38)
Totala
42.6 (4.9)
41.9 (7.8)
t = 0.44
(items 1-12)
Meaninga
14.6 (1.7)
14.2 (3.0)
t = 0.76
(items 2, 3, 5, 8)
Peaceb
13.3 (2.8)
13.0 (2.6)
t = 0.48
(items 1, 4, 6, 7)
Faitha
14.7 (1.9)
14.5 (2.9)
t = 0.45
(items 9, 10, 11, 12)
Note. The total score ranges from 0-48. All subscale scores range from 0-16. A higher
score means higher spiritual well-being, meaning, peace, and faith. n’s ranged from 4145 for African American men and 36-38 for Afro-Caribbean American men due to
missing data.
a
not all participants from both ethnicities answered the question. bnot all African
American participants answered the question.
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Summary
In this population at high risk for aggressive prostate cancer, knowledge
about prostate health and prostate cancer screening participation was low. Likewise,
African American participants felt highly uninformed and unclear of the personal values
of benefits, risks, and side effects that matter most, as related to PSA testing, yet AfroCaribbean American participants felt only moderately uninformed and only moderately
unclear of personal values. Although both African American and Afro-Caribbean
American men felt only moderate overall conflict and uncertainty in their decision and
highly supported in the decision-making process, lack of conflict, certainty in the
decision, and support were insufficient to increase PSA test participation. The greatest
barrier for African American participants was a tie between “Doctor did not tell me I
needed it” and “Can’t afford it,” and for Afro-Caribbean American participants it was
“Exam is embarrassing." For the FACIT-Sp Non-Illness, both ethnicities had high scores
of spiritual well-being in all scales.
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CHAPTER V
DISCUSSION
This chapter discusses the study findings, study limitations, implications,
suggested future research to be conducted based on the findings, and a summary of the
study. All findings are discussed in relation to the HBM and other literature on prostate
health among African American and Afro-Caribbean American men. The study purpose
was to assess the likelihood of action for and factors influencing choice regarding
prostate cancer screenings. It was also to discover if a relationship existed between
ethnicity (African American and Afro-Caribbean American men) and knowledge of
prostate health, self-efficacy (measured by men’s level of conflict in making an informed
decision regarding prostate screening), perceived barriers to prostate screening, and
beliefs measured by spiritual well-being. The findings showed a difference between
ethnicity and perceived barriers of prostate cancer screening, and a similarity between
ethnicity and the level of prostate health knowledge, spiritual well-being, and informed
decision making regarding prostate screening.
This study has helped fill part of the knowledge gap associated with these ethnic
groups at high risk for early-onset and aggressive prostate cancer (Anderson et al., 2013)
by examining results separately and comparing between the two groups. Knowledge
levels, self-efficacy, barriers, and beliefs regarding prostate health reported from African
American and Afro-Caribbean American participants in this study revealed several
similarities and few differences between the two ethnic groups. Both the finding of
similarities and differences provides guidance for educators and researchers when
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addressing the problem of low routine prostate cancer screening rates in a high-risk
population.
Barriers
African American participants reported barriers to screening differently than
Afro-Caribbean American participants in this study. The theoretical construct of the
HBM examined was perceived barriers within both ethnicities. One component of the
HBM indicates a person will take a health-related action if the person feels perceived
benefits outweigh perceived barriers (Lee et al., 2012). Also, while using the HBM as a
framework in a study conducted among a sample of predominantly African American
men, high perceived barriers prevented or delayed the participation in prostate screenings
(Oliver et al., 2011).
Several other studies reported perceived barriers among African American and
Afro-Caribbean American men resulted in less participation in a PSA test, a DRE, or both
(Consedine, 2012; Friedman et al., 2009; Lee et al., 2012; Odedina et al., 2009;
Parchment, 2004; Pedersen et al., 2012). Likewise, in this study, perceived barriers were
identified and screening practices were reportedly low. From the Personal and Family
Health History Questionnaire in this study, approximately half of the African American
participants and one-third of the Afro-Caribbean American participants reported not
knowing they had, or never having had, a PSA test. One-fourth of African American
participants and one-sixth of Afro-Caribbean American participants reported not knowing
they had, or never having had, a DRE. A potential target for intervention work in the
future should be increasing patient knowledge regarding evidence-based screening
practices.
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African American participants reported different barriers to screening than AfroCaribbean American participants. African American participants ranked structural or
societal barriers highest on the Perceived Barriers Survey. The participants indicated the
greatest barriers were “Can’t afford it,” “Doctor did not tell me I needed it,” and “Dislike
or fear of doctors.” African American participants in the focus group also reported
doctor-related barriers, including not receiving a recommendation from the doctor
for prostate cancer screening and overall mistrust of doctors. Afro-Caribbean American
participants ranked personal barriers regarding the screening exam highest: “Exam is
embarrassing” and “Exam is uncomfortable.” Participants in the focus group who were
Afro-Caribbean American also reported fear and pain from the exam as barriers.
These findings were consistent with the literature that African American men
commonly reported barriers to screening as structural or societal, including lack of trust
of the health care system, deficient communication with health care providers,
misunderstanding between diagnostic tests and screening, inconvenient clinic hours, and
limited access to health care services (Friedman et al., 2009). Personal barriers
concerning the screening exam were reported by Afro-Caribbean American participants
in this study. These findings were consistent with other studies of Afro-Caribbean
American men who had fear (Kleier, 2010), anxiety and worry (Consedine, 2012), or
concerns regarding privacy and participating in screening exams (Ng et al., 2013).
African American and Afro-Caribbean American participants identified different
barriers for prostate screening. African American participants were more concerned with
structural or societal barriers. However, Afro-Caribbean American participants were
more concerned with personal barriers.

71

Prostate Knowledge
Total knowledge and symptoms knowledge were low (70% or less) and screening
knowledge was high (greater than 70%) among both ethnicities. Knowledge was a
theoretical construct of the HBM that this study examined. The HBM linked a low level
of knowledge with decreased preventive health behavior for prostate screenings,
according to Holt and colleagues (2009). The researchers concluded knowledge was an
important component needed for informed decision making to participate in prostate
screening. Likewise, low prostate cancer knowledge and low rates of screening have
been observed throughout the United States among various ethnicities (Rivera-Ramos &
Buki, 2011). In this study, low total prostate knowledge and low screening rates were
also reported.
When each question from the questionnaire was considered separately, a question
on urinary symptoms (item 4 “Prostate cancer never causes problems with urination.”)
was the question most participants from both ethnicities answered correctly. However, a
question on urinary symptoms (item 3 “Prostate cancer is the most common cause of
problems with urination.”) was also the question most participants from both ethnicities
answered incorrectly, which revealed participants were unaware of a common symptom.
There is typically a direct relationship between knowledge level and preventive health
behavior practices (Rivera-Ramos & Buki, 2011). Consistent with this association
between knowledge and behavior, most study participants had a low level of knowledge
and reported low screening behavior in relation to their risk of prostate cancer.
The items on the Prostate Knowledge Scale were interpreted as a high level of
knowledge if the score was greater than 70% on the scale or subscale, and a low level of
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knowledge if lower than 70% (Adesanya et al., 2013; Radosevich et al., 2004). Results
were compared to related research on prostate health knowledge, and knowledge scores
were expected to be low based on the low knowledge results among men of African
descent from other studies (Odedina et al., 2011; Rivers et al., 2010). In addition,
Odedina and colleagues (2011) stated a reason for prostate cancer disparities was low
knowledge levels regarding prostate cancer among men of African descent.
In this study, both African American and Afro-Caribbean American participants
demonstrated a low level of prostate health knowledge. Overall knowledge levels were
consistent with previous research, but high levels of screening knowledge were observed.
However, for this high-risk group, knowledge about screening was not associated with
increased prostate cancer screening behavior, as evidenced by the fact that almost half of
the African American and nearly a third of the Afro-Caribbean American participants did
not have a PSA blood test done, or did not know if one was conducted. Although the
study participants were knowledgeable about prostate screening, this did not result in
seeking preventive health services.
Beliefs
Both African American and Afro-Caribbean American participants had high
levels of spirituality. Although spiritual well-being is not a theoretical construct of the
HBM, it has been related to other theoretical constructs, including knowledge and selfefficacy (Drake et al., 2010; Holt et al., 2009). Spiritual well-being was investigated in
this study because all participants are members of a Christian church community; and a
previous study found people who actively attended religious groups or services have
higher spiritual well-being, as well as improved health, and lived longer than those who
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did not (Stojković & Prlić, 2012). However, increased spirituality does not necessarily
require church attendance (Holt et al., 2009). Spirituality has been observed to be
positively correlated with well-being (Visser et al. 2010).
As found by Stojković and Prlić (2012), the majority of the study participants from both
ethnicities showed high levels of spiritual well-being in this study.
Saunders and colleagues (2013) found the majority of African American men
were highly involved in, and frequently attended, churches. This involvement could
increase spiritual well-being and make churches successful settings for prostate health
interventions (Stojković & Prlić, 2012). In addition, using churches as settings has
helped educate African American men (Drake et al., 2010; Holt et al., 2009; Jackson et
al., 2014; Parchment, 2004) and Afro-Caribbean American men (Parchment, 2004)
regarding prostate health issues and screening practices.
Community involvement in churches has been shown to increase the number of
African American men willing to complete prostate screenings (Emerson et al., 2009;
Holt et al., 2009). A church-based intervention was tested in predominantly African
American churches and showed an increase in informed decision making, knowledge,
and self-efficacy in terms of prostate screening (Drake et al., 2010). Holt and colleagues
(2009) piloted a spiritually based educational intervention among African American men
and found knowledge and self-efficacy for informed decision making in regards to
prostate screening increased in a spiritually based group to a greater degree than the nonspiritually based group.
Churches were also the setting of this study, and all five churches were part of a
faith-based and medical center partnership called CHAMP. The churches were the faith-
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based organizations and consisted of various Christian denominations throughout the
community. The medical partner was Baptist Health System of South Florida, which is a
faith-based medical organization guided by Christian values with a goal to improve the
well-being of the community. The similar mission of the faith-based organizations and
the medical partner strengthens their relationship and optimizes their goal of improving
health in the South Florida community.
Partnerships between faith-based organizations and medical centers were studied
by Kegler, Hall, and Kiser (2010), who found an overall use of resources increased and
health disparities decreased in communities where faith-based and health organizations
collaborated. Similarly, Levin (2014) reported these partnerships have been successful at
providing health care, especially to underserved populations, and have helped decrease
health disparities in the United States. These partnerships have expanded to the national
level to produce federal faith-based resources that assist in accomplishing Healthy People
2020 goals, decreasing health disparities, and improving use of health resources across
the nation (Levin, 2014). Therefore, faith-based and medical partnerships could be used
more frequently and continued as a nationally led initiative. According to Levin (2014),
this national initiative was started during the Clinton Administration, with the signing of
the “charitable choice” doctrine in 1996. It was sustained with the development of the
White House Office of Faith-Based and Community Initiatives by the Bush
Administration in 2001. Subsequently, it continued through the Obama Administration,
within the Department of Health and Human Services, and was renamed as the Office of
Faith-Based and Neighborhood Partnerships (Levin, 2014).
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Decisional Conflict
Self-efficacy in this study was measured by men’s level of conflict in making an
informed decision regarding prostate screening using the Decisional Conflict Scale.
African American participants felt highly uninformed and Afro-Caribbean American
participants felt moderately uninformed. However, both ethnicities felt highly supported
in the decision-making process. Support from family and friends was an important
factor, identified during the focus group, in reducing decisional conflict for both
ethnicities.
Men of African descent having perceived high levels of support in their prostate
screening decisions was consistent with the literature. Jones and colleagues (2010)
reported African American men participated in prostate screenings when a friend and/or
family member had prostate cancer and if friends and/or family were involved in the
decision-making process. Participants in this study of active church members found
perceived high levels of support for screening decisions. This is consistent with the
findings of another study that reported African American men experience high levels of
perceived support from church membership in making screening decisions (Holt, 2009).
Although both African American and Afro-Caribbean American participants reported
high levels of support and moderate total decisional conflict regarding intent to
participate in a PSA testing, actual screening practices were reportedly low.
Perceived Cost
Perceived cost is a theoretical construct from the HBM. Although this study did
not measure perceived cost specifically, perceived cost barriers to screening were
measured. Interestingly, although approximately half (52.2%) of participants reported
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having private health insurance and greater than one in four had public insurance (i.e.,
Medicare or Medicaid), the barrier of “Can’t afford it” was still ranked high among
African American participants (tied for the highest-ranked barrier) and both ethnicities
ranked “No insurance” (reported in 8% of participants) as the third greatest barrier.
Previously, a lack of health insurance has been found to lead to men not participating in
prostate screenings (Burns, Walsh, Sharp, & O'Neill, 2012).
The Patient Protection and Affordable Care Act expanded insurance coverage to
approximately 30 million Americans (Andrews et al., 2013), and the coinsurance and
deductible payments were waived for PSA screenings through the Social Security Act.
Therefore, the barrier of not being able to afford screening should see a reduction over
time (Stranne, 2011). Burns and colleagues (2012) found men with private health
insurance were more likely to participate in a PSA screening than men without it, and
private health insurance coverage was the biggest factor in contributing to differences in
screening practices among men. By increasing knowledge regarding coverage of
insurance for prostate cancer screening, fewer men should view “financial cost” as a
barrier for screening.
Still, other costs, in addition to the blood work and office visit exam involved
with screenings, may have been factors influencing the perceived cost barrier reported in
this study. Martin, Lord, Verry, Stockler, and Emery (2013) found some costs of
screening were inconvenience of the screening, side effects from treating indolent
tumors, and harm from biopsies. It is expected that with increased knowledge regarding
both screening insurance coverage and cost of managing prostate cancer in low-risk
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stages versus high-risk stages among men from both ethnicities, the barrier of “Can’t
afford it” should decrease and more men should participate in prostate screening.
Age
Age is an important characteristic to consider when planning prostate cancer
education, and African American men had an improved response to education when
materials were tailored to their age (Friedman et al., 2009). Both groups in this study had
a mean age of over 45, and all participants in the study by Friedman and colleagues
(2009) were 45 or older, so the approaches in education and recommendations would be
comparable. Age was also a predictive variable for African American men participating
in a prostate cancer screening (Lehto et al., 2010). Lehto and colleagues (2010) reported
men 50 or older were more likely to participate in screenings than men younger than 50.
Again, both groups in this study had a mean age over 50, and Lehto and colleagues
(2010) found a difference only between men younger than 50 and men aged 50 or older.
Younger men, including any man older than 21, could have participated in this
study. Younger men were not excluded from this study because limited research
regarding prostate cancer has been completed among men of African descent younger
than 45 (Miller, 2014). Because the American Cancer Society (2015) recommends men
of African descent to begin discussion with their health care provider regarding prostate
cancer screening after 45 years of age, less research has been conducted among men
younger than 45. However, earlier outreach to younger men is important in order to
increase knowledge of screening and health values before men of African descent turn 45
and need to make a decision regarding prostate cancer screening (Lehto et al., 2010).
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The American Cancer Society (2015) reported 56% of prostate cancer cases were
diagnosed in men aged 65 or older and 97% were diagnosed in men aged 50 or older, and
the average age of diagnosis was approximately 66. The mean age for African American
participants was 53.4 and for Afro-Caribbean American participants, it was 61.2 years
old. There was a statistically significant difference in mean age in this study between the
two groups. The importance of the difference in mean age was decreased because the
mean ages for participants in both ethnic groups were older than 45, which was the
recommended age for men of African descent to start counseling with a health care
provider concerning screening, as per the American Cancer Society (2015).
Limitations
Some limitations of this study were observed. First, the limitation of self-reported
prostate screening participation without data gathered from medical records was noted
(Polit, 2010; Waltz, Strickland, & Lenz, 2010). It is possible participants were involved
in PSA and DRE testing without being aware. Not being aware if testing had occurred is
problematic, as the individual would not know when to seek further screening and how
often these appointments should occur.
Second, data regarding the participants’ preference to participate in PSA testing
was collected, but not DRE testing. Decisional conflict regarding PSA testing could have
been different from the decisional conflict regarding DRE testing. The DRE test is an
invasive test performed by a health care provider, who checks for abnormalities by
palpating the prostate through introduction of a finger into the rectum (Wray et al., 2009).
Also, men reportedly have not participated in DRE testing because they felt embarrassed
to get an exam and lacked knowledge of the screening procedure (Ferrant et al., 2011).
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Differences in preference to participate in a DRE versus a PSA test could be due to the
nature of the DRE exam, personal factors, and lack of knowledge regarding the DRE
exam itself (Ferrant et al., 2011; Wray et al., 2009).
Finally, the study only sampled participants using convenience sampling from
participants who were easily accessible to the PI. Only one network of churches in a
single region was used for recruiting participants, and men were not queried about their
country of origin and length of time living in the United States. Therefore, these findings
have uncertain generalizability to men from other religious organizations and various
settings (Polit, 2010; Waltz et al., 2010). Men from different countries of origin with
various levels of acculturation from living in the United States could have differing
knowledge and beliefs regarding prostate health. However, these findings are consistent
with other studies. Rivera-Ramos and Buki (2011) also reported low prostate cancer
knowledge among men of various ethnicities throughout the United States. In addition,
other researchers reported similar barriers and beliefs regarding prostate screening
practices, including lack of trust of the health care system, deficient communication with
health care providers, misunderstanding between diagnostic tests and screening,
(Friedman et al., 2009), fear of screening (Kleier, 2010), and anxiety and worry
concerning screening (Consedine, 2012).
Implications
This study was able to fill some gaps in the current literature on prostate health
knowledge, self-efficacy in screening decision making, perceived barriers regarding
prostate screening, and spiritual well-being as related to the theoretical constructs of the
HBM among African American and Afro-Caribbean American men. Findings
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contributed to the body of knowledge by noting decreased screening practices were
related to issues concerning prostate cancer screening, lack of knowledge, and past
negative experiences. The implications of these findings could be categorized into three
main areas: patient education, faith-based and medical partnerships, and improved
nursing practice.
First, data from this study indicating a disparity between high levels of prostate
screening knowledge and low screening behavior could be used in conjunction with other
studies to determine further factors influencing screening behavior. With this
combination of findings, health care professionals could create an improved, culturally
appropriate educational modality best suited for informed decision making regarding
prostate screening and increase screening behavior among African American and AfroCaribbean American men (Drake et al., 2010; Friedman et al., 2009; Miller, 2014; Patel
et al., 2013; Smith et al., 2012; Wolf et al., 2010).
Second, the findings have an implication for a continued implementation of the
local faith-based medical partnerships, such as the CHAMP partnership, with nationally
recognized partnerships, in order to help diminish knowledge gaps and health disparities
(Levin, 2014). Churches, working in collaboration with other organizations in the
community, have already been settings for health-related programs where African
American men have improved health behaviors, and health disparities have decreased
(Saunders et al., 2013). The above-mentioned national partnerships expand accessibility
and help disseminate prostate screening awareness. Another concrete reason for utilizing
national partnerships is Miller’s (2014) finding that the health disparity of mortality rate
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from prostate cancer among African American men has decreased as participation in
prostate cancer screening has increased.
A health disparity, however, still is apparent in the United States in regards to
prostate cancer and ethnicity (U.S. Department of Health and Human Services, 2014).
According to the U.S. Cancer Statistics Working Group (2014), the age-adjusted
incidence rate for prostate cancer per 100,000 men for all races is 128.3, and Black is the
ethnicity with the highest rate at 194.7 per 100,000 men. The Healthy People 2020 goal
is to reduce the prostate cancer death rate from the baseline of 24.2 per 100,000 men from
2007 to the target of 21.8 per 100,000 men (U.S. Department of Health and Human
Services, 2014). Educators, clinicians, and researchers working to achieve the Healthy
People 2020 goal of decreasing the prostate cancer death rate should consider including
faith-based medical partnerships for high-risk African American and Afro-Caribbean
American men.
Third, the study findings have implications for nurses and other health
professionals working to inform men of African descent about specific risks and benefits
regarding prostate cancer screening. Health care professionals can take the lead in
discussions to help men make an informed decision regarding screening by presenting
men with culturally relevant messages and easily understood information (Miller, 2014),
consistent with the American Cancer Society’s (2015) recommendation.
Nurses and other professionals at the bedside, in clinics, in medical offices, and in
the community, including churches, can help address this public health problem through
culturally appropriate education. Discussions with men and potentially their family
members about prostate cancer screening should not only take place during a primary
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care office visit, when there are often competing priorities. Health care workers require
improved tools to help patients make informed decisions regarding screening for prostate
cancer, which could improve overall patient care, health outcomes, and decrease costs.
Future Research
Future studies should include the development and testing of culturally
appropriate strategies and tools for nurses and other health care providers to use to
promote informed decision making concerning prostate cancer screening. Theoretical
constructs of the HBM, including perceived susceptibility, perceived severity, cues to
action, perceived cost, and perceived benefits, require further study. To diminish the
health disparity regarding prostate cancer morbidity and mortality, research focused on
the influence of culture on informed decision making and readiness to participate in
routine prostate cancer screening is needed.
Summary
The purpose of this study was to assess the likelihood of action for, and factors
influencing, choice regarding prostate cancer screenings. It was also to discover if a
relationship existed between ethnicity (African American and Afro-Caribbean American
men) and knowledge of prostate health, self-efficacy (measured by men’s level of
conflict in making an informed decision regarding prostate screening), perceived barriers
to prostate screening, and beliefs measured by spiritual well-being. Results from this
study showed there was a relationship between ethnicity (African American and AfroCaribbean American men) and the influencing factor of perceived barriers on prostate
cancer screening behavior. African American participants reported structural or societal
barriers to screening, yet Afro-Caribbean American participants reported personal
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barriers to screening. Also, there was a relationship between ethnicity (African American
and Afro-Caribbean American men) and level of prostate health knowledge. Both
ethnicities had low total prostate knowledge. In addition, there was a relationship
between ethnicity (African American and Afro-Caribbean American men) and the
influencing factor of beliefs measured by spiritual well-being on screening behavior.
Both ethnicities had high spiritual well-being. Furthermore, there was a relationship
between ethnicity (African American and Afro-Caribbean American men) and informed
decision making self-efficacy measured by men’s level of conflict regarding prostate
screening. Both African American and Afro-Caribbean American participants had
moderate total decisional conflict.
The study findings demonstrated several barriers to screening, low knowledge
levels, and moderate conflict in making a decision to participate in prostate cancer
screenings, which are likely reasons for almost half of African American participants
(47.9%) and nearly a third of Afro-Caribbean American participants (29%) not to
participate in a PSA blood test (or not know if one was conducted). With decreased
participation in prostate cancer screenings, mortality rates increase, contributing to the
disparity of higher mortality rates from prostate cancer among these ethnic groups than
among other ethnicities. Therefore, the study findings reaffirm the existence of a
disparity regarding prostate cancer among the high-risk ethnic groups of African
American and Afro-Caribbean American men. The results signal the necessity for further
research and imply a need for more culturally appropriate education for these ethnic
groups. Much has been done, but these findings indicate more still needs to be done to
close the disparity and achieve the Healthy People 2020 goal of decreasing the mortality
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rate from prostate cancer. These study findings have implications for patient education,
faith-based and medical partnerships, and improved health outcomes for a population at
high risk for prostate cancer morbidity and mortality.
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APPENDIX A
Survey: Demographic Questionnaire
Instructions: Please enter your age on the first question, then place an X in the box
before the answer you would like to choose.
1. How many years old are you today? ________
2. How do you identify your race? [] Black, [] Caucasian, [] Latino, [] Native
American, [] Asian/Pacific Islander, [] Other (specify)_____________
3. How do you identify your Ethnicity? [] Hispanic, [] African-American, [] AfroCaribbean, [] Other (specify)__________
4. What is your marital status? [] Single [] Widower [] Divorced [] Married []
Partnered
5. What is the highest education level you have completed?
[] Less than high school/GED [] High school/GED [] Associates degree or some
college or trade school [] Bachelor’s degree [] Post-baccalaureate education
6. What is your household annual income or salary?
[]<$20,000[]$20,000 to <$40,000[]$40,000 to < $60,000[]$60,000 to < $80,000
[]>$80,000
7. What is your health insurance coverage?
[] Private insurance (Such as Blue Cross/Blue Shield)
[] Public insurance (Such as Medicaid, Medicare) [] No health insurance
8. What religion do you affiliate with?
[] Catholic [] Protestant [] Jehovah’s Witness [] Mormon/LDS [] Jewish []
Muslim
[] Hindu [] Buddhist [] None [] Atheist [] Agnostic [] Other
(specify) _____________
Personal and Family Health History Questionnaire
Instructions: Please place an X in the box before the answer you would like to choose.
1. Is there a history of prostate cancer in your family?
[] Yes [] No [] I don’t know
2. Has your doctor ever checked your prostate?
[] Yes [] No [] I don’t know
3. Have you ever had a prostate-specific antigen (PSA) blood test?
[] Yes [] No [] I don’t know
4. Have you ever had any of these problems? Difficulty urinating, pain on urination,
frequent urination, blood in the urine.
[] Yes [] No [] I don’t know
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Prostate Knowledge:
Instructions:
Mark each statement true or false with an X.
1. Most men diagnosed as having prostate cancer die of something else.
[] True [] False
2.

Men are more likely to die because of prostate cancer than because of heart
disease.
[] True [] False

3.

Prostate cancer is the most common cause of problems with urination.
[] True [] False

4. Prostate cancer never causes problems with urination.
[] True [] False
5. Prostate cancer is one of the least common cancers among men.
[] True [] False
6. If you have an abnormal prostate-specific antigen (PSA) test result, your doctor
may recommend that you have a prostate biopsy.
[] True [] False
7. The prostate-specific antigen (PSA) test will pick up all prostate cancers
[] True [] False
8. A prostate biopsy can tell you with more certainty whether you have prostate
cancer than a prostate-specific antigen (PSA) test can.
[] True [] False
9.

Loss of sexual function is a common side effect of prostate cancer treatments.
[] True [] False

10. Problems with urination are common side effects of prostate cancer treatments.
[] True [] False
11. The prostate is an accessory organ of reproduction.
[] True [] False
12. The prostate is located in the thorax of the body.
[] True [] False
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Decisional Conflict Scale:
Instructions: Which do you prefer? Please check one.
a. Getting a prostate-specific antigen PSA test []
b. NOT getting a prostate-specific antigen PSA test []
c. Unsure []
Instructions: Considering the option you prefer, please answer the following questions:
1. Do you know which options are available to you?
[]Yes []Unsure []No
2. Do you know the benefits of each option?
[]Yes []Unsure []No
3. Do you know the risks and side effects of each option?
[]Yes []Unsure []No
4. Are you clear about which benefits matter most to you?
[]Yes []Unsure []No
5. Are you clear about which risks and side effects matter most to you?
[]Yes[]Unsure[]No
6. Do you have enough support from others to make a choice?
[]Yes []Unsure []No
7. Are you choosing without pressure from others?
[]Yes []Unsure []No
8. Do you have enough advice to make a choice?
[]Yes []Unsure []No
9. Are you clear about the best choice for you?
[]Yes []Unsure []No
10. Do you feel sure about what to choose?
[]Yes []Unsure []No
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Possible Barriers to Screening:
Instructions:
Please rate the reasons that you might not participate in a prostate screening from greatest
to least with one (1) being the first or main reason you might not participate to eleven
(11) being the reason you are least concerned about.
Perceived Barrier:
Ranking 1-11
Dislike or fear of doctors
Can’t afford it
Fear of finding cancer
No insurance
No transportation
Exam is embarrassing
Past problems with doctors
Did not think it was important
Doctor did not tell me I needed it
Personal or religious beliefs
Exam is uncomfortable
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FACIT-Sp-12 (Version 4)
Functional Assessment of Chronic Illness Therapy - Spiritual Well-Being, a
modified version for non-illness
Please circle or mark one number per line to indicate your response as it applies to
the past 7 days.
ADDITIONAL CONCERNS
Not
A
Some- Quite Very
at little what a bit much
all
bit
1.

I feel peaceful.................................................

0

1

2

3

4

2. I have a reason for living................................

0

1

2

3

4

3. My life has been productive............................

0

1

2

3

4

4. I have trouble feeling peace of mind...............

0

1

2

3

4

5. I feel a sense of purpose in my life.................

0

1

2

3

4

6. I am able to reach down deep into myself for
comfort............................................................

0

1

2

3

4

7. I feel a sense of harmony within myself.........

0

1

2

3

4

8. My life lacks meaning and purpose................

0

1

2

3

4

9. I find comfort in my faith or spiritual beliefs..

0

1

2

3

4

10. I find strength in my faith or spiritual beliefs.

0

1

2

3

4

11. Difficult times have strengthened my faith or
spiritual beliefs................................................

0

1

2

3

4

12. Even during difficult times, I know that
things will be okay..........................................

0

1

2

3

4

English (Universal) 16 November 2007 Copyright 1987, 1997
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APPENDIX B
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APPENDIX C
Table C1
Major Concepts and Empirical Indicators
Variable
Independent Variable(IV) 1=
How many years old are you today? ______
Independent Variable(IV) 2=
How do you identify your race? [] Black, []
Caucasian, [] Latino, [] Native American, []
Asian/Pacific Islander, [] Other (specify)______
Independent Variable(IV) 3=
How do you identify your Ethnicity? []
Hispanic, [] African-American, [] AfroCaribbean, [] Other (specify)______
Independent Variable(IV) 4=
What is your marital status? [] Single
[] Widower [] Divorced [] Married [] Partnered
Independent Variable(IV) 5=
What is the highest education level you have
completed?
[]Less than high school/GED []High
school/GED []Associates degree or some
college or trade school []Bachelor’s
degree[]Post-baccalaureate education
Independent Variable(IV) 6=
What is your household annual income or
salary?
[]<$20,000[]$20,000 to <$40,000[]$40,000 to <
$60,000[]$60,000 to < $80,000 []>$80,000
Independent Variable(IV) 7=
What is your health insurance coverage?
[] Private insurance (Such as Blue Cross/Blue
Shield) [] Public insurance (Such as Medicaid,
Medicare) [] No health insurance
Independent Variable(IV) 8=
What religion do you affiliate with?
[] Catholic [] Protestant [] Jehovah’s Witness []
Mormon/LDS [] Jewish [] Muslim
[]
Hindu [] Buddhist [] None [] Atheist []
Agnostic [] Other (specify) ______
Independent Variable(IV) 9=
Is there a history of prostate cancer in your
family?
[] Yes [] No [] I don’t know
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Instrument
Demographic
Questionnaire
Demographic
Questionnaire

Reference
Parchment,
2004.
Parchment,
2004.

Demographic
Questionnaire

Parchment,
2004.

Demographic
Questionnaire

Parchment,
2004.

Demographic
Questionnaire

Parchment,
2004.

Demographic
Questionnaire

Parchment,
2004.

Demographic
Questionnaire

Parchment,
2004.

Demographic
Questionnaire

Parchment,
2004.

Personal and
Family Health
History
Questionnaire

Parchment,
2004.

Independent Variable(IV) 10=
Has your doctor ever check your prostate?
[] Yes [] No [] I don’t know
Independent Variable(IV) 11=
Have you ever had a prostate-specific antigen
(PSA) blood test?
[] Yes [] No [] I don’t know
Independent Variable(IV) 12=
Have you ever had any of these problems?
Difficulty urinating, pain on urination, frequent
urination, blood in the urine.
[] Yes [] No [] I don’t know
Dependent Variable(DV) 1=
Most men diagnosed as having
prostate cancer die of something else
[] True [] False
Dependent Variable(DV) 2=
Men are more likely to die because of
prostate cancer than because of heart
disease
[] True [] False
Dependent Variable(DV) 3=
Prostate cancer is the most common
cause of problems with urination
[] True [] False
Dependent Variable(DV) 4=
Prostate cancer never causes problems
with urination
[] True [] False
Dependent Variable(DV) 5=
Prostate cancer is one of the least
common cancers among men
[] True [] False
Dependent Variable(DV) 6=
If you have an abnormal prostate
specific antigen (PSA) test result,
your doctor may recommend that you
have a prostate biopsy
[] True [] False
Dependent Variable(DV) 7=
The prostate-specific antigen (PSA)
test will pick up all prostate cancers
[] True [] False
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Personal and
Family Health
History
Questionnaire
Personal and
Family Health
History
Questionnaire
Personal and
Family Health
History
Questionnaire

Parchment,
2004.

Prostate Cancer
Screening
Education
(PROCASE)
Knowledge Index
PROCASE
Knowledge Index

Radosevich et
al., 2004.

PROCASE
Knowledge Index

Radosevich et
al., 2004.

PROCASE
Knowledge Index

Radosevich et
al., 2004.

PROCASE
Knowledge Index

Radosevich et
al., 2004.

PROCASE
Knowledge Index

Radosevich et
al., 2004.

PROCASE
Knowledge Index

Radosevich et
al., 2004.

Parchment,
2004.

Parchment,
2004.

Radosevich et
al., 2004.

Dependent Variable(DV) 8=
A prostate biopsy can tell you with
more certainty whether you have
prostate cancer than a prostate-specific antigen
(PSA) test can
[] True [] False
Dependent Variable(DV) 9=
Loss of sexual function is a common
side effect of prostate cancer
treatments
[] True [] False
Dependent Variable(DV) 10=
Problems with urination are common
side effects of prostate cancer
treatments
[] True [] False
Dependent Variable(DV) 11=
The prostate is an accessory organ of
reproduction
[] True [] False
Dependent Variable(DV) 12=
The prostate is located in the thorax of the body
[] True [] False

Dependent Variable(DV) 13=
Do you know which options are available to
you?
[] Yes [] Unsure [] No
Dependent Variable(DV) 14=
Do you know the benefits of each option?
[] Yes [] Unsure [] No
Dependent Variable(DV) 15=
Do you know the risks and side effects of each
option?
[] Yes [] Unsure [] No
Dependent Variable(DV) 16=
Are you clear about which benefits matter most
to you?
[] Yes [] Unsure [] No
Dependent Variable(DV) 17=
Are you clear about which risks and side effects
matter most to you?
[] Yes [] Unsure [] No
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PROCASE
Knowledge Index

Radosevich et
al., 2004.

PROCASE
Knowledge Index

Radosevich et
al., 2004.

PROCASE
Knowledge Index

Radosevich et
al., 2004.

Knowledge
and Practice
of Prostate
Health
Questionnaire
Knowledge
and Practice
of Prostate
Health
Questionnaire
Low Literacy
Decisional Conflict
Scale

Adesanya,
Shittu,
Awobajo,
Otulana, &
Adesanya, 2013
Adesanya et al.,
2013.

Low Literacy
Decisional Conflict
Scale
Low Literacy
Decisional Conflict
Scale

O’Connor,
1995.

Low Literacy
Decisional Conflict
Scale

O’Connor,
1995.

Low Literacy
Decisional Conflict
Scale

O’Connor,
1995.

O’Connor,
1995.

O’Connor,
1995.

Dependent Variable(DV) 18=
Do you have enough support from others to
make a choice?
[] Yes [] Unsure [] No
Dependent Variable(DV) 19=
Are you choosing without pressure from others?
[] Yes [] Unsure [] No
Dependent Variable(DV) 20=
Do you have enough advice to make a choice?
[] Yes [] Unsure [] No
Dependent Variable(DV) 21=
Are you clear about the best choice for you?
[] Yes [] Unsure [] No
Dependent Variable(DV) 22=
Do you feel sure about what to choose?
[] Yes [] Unsure [] No
Dependent Variable(DV) 23=
Please rate the reasons that you might not
participate in a prostate screening from greatest
(being number one (1)) to least (being number
eleven (11)):
[] Dislike or fear of doctors
[] Can’t afford it
[] Fear of finding cancer
[] No insurance
[] No transportation
[] Exam is embarrassing
[] Past problems with doctors
[] Did not think it was important
[] Doctor did not tell me I needed it
[] Personal or religious beliefs
[] Exam is uncomfortable
Dependent Variable(DV) 24=
I feel peaceful
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much

Dependent Variable(DV) 25=
I have a reason for living
[]Not at all [] A little bit []Somewhat
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Low Literacy
Decisional Conflict
Scale

O’Connor,
1995.

Low Literacy
Decisional Conflict
Scale
Low Literacy
Decisional Conflict
Scale
Low Literacy
Decisional Conflict
Scale
Low Literacy
Decisional Conflict
Scale
Perceived Barriers
of the Cancer
Awareness Survey

O’Connor,
1995.

Functional
Assessment of
Chronic Illness
Therapy-Spiritual
Well-Being, a
modified version
for non-illness
(FACIT-Sp NonIllness) (peace
subscale)
FACIT-Sp nonillness (meaning
subscale)

Visser, Garssen,
& Vingerhoets
(2010)

O’Connor,
1995.
O’Connor,
1995.
O’Connor,
1995.
Parchment,
2004.

Visser et al.,
2010.

[] Quite a bit [] Very much
Dependent Variable(DV) 26=
My life has been productive
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 27=
I have trouble feeling peace of mind
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 28=
I feel a sense of purpose in my life
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 29=
I am able to reach down deep into myself for
comfort
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 30=
I feel a sense of harmony within myself
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 31=
My life lacks meaning and purpose
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 32=
I find comfort in my faith or spiritual beliefs
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 33=
I find strength in my faith or spiritual beliefs
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 34=
Difficult times have strengthened my faith or
spiritual beliefs
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
Dependent Variable(DV) 35=
Even during difficult times, I know that things
will be okay
[]Not at all [] A little bit []Somewhat
[] Quite a bit [] Very much
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FACIT-Sp nonillness (meaning
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (peace
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (meaning
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (peace
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (peace
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (meaning
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (faith
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (faith
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (faith
subscale)

Visser et al.,
2010.

FACIT-Sp nonillness (faith
subscale)

Visser et al.,
2010.
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